CERNER CORPORATION
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
43-1196944
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
2800 Rockcreek Parkway
North Kansas City, MO
|
64117
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
|
The Nasdaq Stock Market LLC
(Nasdaq Global Select Market)
|
Class
|
|
Outstanding at January 28, 2019
|
Common Stock, $0.01 par value per share
|
|
324,360,908 shares
|
Document
|
|
Parts into Which Incorporated
|
Portions of the registrant's Proxy Statement for the Annual Shareholders' Meeting to be held May 30, 2019
|
|
Part III
|
Part I
|
|
|
Item 1.
|
Business
|
|
Item 1A.
|
Risk Factors
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
Item 2.
|
Properties
|
|
Item 3.
|
Legal Proceedings
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
|
|
Part II
|
|
|
Item 5.
|
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
Item 6.
|
Selected Financial Data
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
Item 9A.
|
Controls and Procedures
|
|
Item 9B.
|
Other Information
|
|
|
|
|
Part III
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
Item 11.
|
Executive Compensation
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
|
Item 14.
|
Principal Accountant Fees and Services
|
|
|
|
|
Part IV
|
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
|
|
|
Item 16.
|
Form 10-K Summary
|
|
|
|
|
Signatures
|
|
For the Years Ended
|
|||||
|
2018
|
2017
|
2016
|
|||
|
|
|
|
|||
Revenues by Business Models
|
|
|
|
|||
Licensed software
|
11
|
%
|
12
|
%
|
11
|
%
|
Technology resale
|
5
|
%
|
5
|
%
|
6
|
%
|
Subscriptions
|
6
|
%
|
9
|
%
|
9
|
%
|
Professional services
|
34
|
%
|
31
|
%
|
30
|
%
|
Managed services
|
21
|
%
|
21
|
%
|
21
|
%
|
Support and maintenance
|
21
|
%
|
20
|
%
|
21
|
%
|
Reimbursed travel
|
2
|
%
|
2
|
%
|
2
|
%
|
|
100
|
%
|
100
|
%
|
100
|
%
|
|
|
|
|
|||
Revenues by Segment
|
|
|
|
|||
Domestic
|
88
|
%
|
89
|
%
|
89
|
%
|
Global
|
12
|
%
|
11
|
%
|
11
|
%
|
|
100
|
%
|
100
|
%
|
100
|
%
|
•
|
KNOW what is happening and predict what will happen within their population through solutions for data exchange, longitudinal record, enterprise data warehouse, analytics and quality and regulatory reporting;
|
•
|
ENGAGE providers and patients in health and care delivery through personal health portals and solutions for care management, home care, long-term care, and retail pharmacy; and
|
•
|
MANAGE health and improve care with capacity and workforce management, clinical research, predictive modeling, health registries, and contract and network management.
|
•
|
Longitudinal Record
- provides clinicians and the patient a view of their consolidated clinical record, gathered and normalized from multiple sources.
|
•
|
Registries and Scorecards
- identifies and automatically segments patients by disease, guides interventions according to clinical best practice, provides visibility to quality measures for provider's population, produces client-defined performance scorecards, and tracks their health and their interventions according to clinical best practice.
|
•
|
Enterprise and Population Health Analytics
- allows the integrated data to be analyzed for the purpose of population health management and research.
|
•
|
Provider Performance Management
- creates visibility for providers on their performance against key clinical and operation metrics and can be aligned with payment models that incentivize high quality and efficient care.
|
•
|
Patient/Member Engagement
- an enhanced patient portal complemented by engagement services to help health care organizations create more meaningful interactions and engagement with the members they serve, and provides the ability to target individuals at risk of becoming chronically ill.
|
•
|
Community Care Management
- provides a person-centric approach of proactive surveillance, coordination and facilitation of health services across the care continuum to achieve optimal health status, quality and costs.
|
•
|
Population Health Programs
- leverages evidence-based guidelines and the contextual information within
HealtheIntent
to provide identification, prediction and management of a condition at the population, provider and person level and facilitates a personalized plan of care for each member.
|
•
|
Contract and Network Management
- for managing provider networks, modeling to inform payer negotiations, determining appropriate business models, and managing contract performance in near real-time.
|
Name
|
|
Age
|
|
Positions
|
Brent Shafer
|
|
61
|
|
Chairman of the Board of Directors and Chief Executive Officer
|
|
|
|
|
|
Marc G. Naughton
|
|
63
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
|
|
Michael R. Nill
|
|
54
|
|
Executive Vice President and Chief Operating Officer
|
|
|
|
|
|
John Peterzalek
|
|
58
|
|
Executive Vice President and Chief Client Officer
|
|
|
|
|
|
Randy D. Sims
|
|
58
|
|
Executive Vice President, Chief Legal Officer and Secretary
|
|
|
|
|
|
Jeffrey A. Townsend
|
|
55
|
|
Executive Vice President and Chief of Innovation
|
|
|
|
|
|
Donald Trigg
|
|
47
|
|
Executive Vice President, Strategic Growth
|
|
|
|
|
|
Julia M. Wilson
|
|
56
|
|
Executive Vice President and Chief People Officer
|
•
|
Greater difficulty in collecting accounts receivable and longer collection periods;
|
•
|
Difficulties and costs of staffing and managing non-U.S. operations;
|
•
|
The impact of global economic and political market conditions;
|
•
|
Effects of sovereign debt conditions, including budgetary constraints;
|
•
|
Unfavorable or volatile foreign currency exchange rates;
|
•
|
Legal compliance costs or business risks associated with our global operations where: i) local laws and customs differ from, or are more stringent than those in the U.S., such as those relating to data protection and data security, or ii) risk is heightened with respect to laws prohibiting improper payments and bribery, including without limitation the U.S. Foreign Corrupt Practices Act, the U.K. Anti-Bribery Act and similar laws and regulations in foreign jurisdictions;
|
•
|
Certification, licensing or regulatory requirements and unexpected changes to those requirements;
|
•
|
Changes to or reduced protection of intellectual property rights in some countries;
|
•
|
Potentially adverse tax consequences as a result of changes in tax laws or otherwise, and difficulties associated with repatriating cash generated or held abroad in a tax-efficient manner;
|
•
|
Different or additional functionality requirements or preferences;
|
•
|
Trade protection measures;
|
•
|
Export control regulations;
|
•
|
Health service provider or government spending patterns or government-imposed austerity measures;
|
•
|
Natural disasters, war or terrorist acts;
|
•
|
Labor disruptions that may occur in a country; and
|
•
|
Political unrest which may impact sales or threaten the safety of associates or our continued presence in these countries and the related potential impact on global stability.
|
•
|
Government entities, particularly in the U.S., often reserve the right to audit our contracts and conduct inquiries and investigations of our business practices with respect to government contracts. U.S. government agencies conduct reviews and investigations and make inquiries regarding our systems in connection with our performance and business practices with respect to our government contracts. Negative findings from audits, investigations or inquiries could affect our future sales and profitability by preventing us, by operation of law or in practice, from receiving new government contracts for some period of time.
|
•
|
If a government client discovers improper or illegal activities during its audits or investigations, we may become subject to various civil and criminal penalties, including those under the civil U.S. False Claims Act, and administrative sanctions, which may include termination of contracts, suspension of payments, fines and suspensions or debarment from doing business with other agencies of that government. The inherent limitations of internal controls may not prevent or detect all improper or illegal activities.
|
•
|
U.S. government contracting regulations impose strict compliance and disclosure obligations. Disclosure is required if certain company personnel have knowledge of "credible evidence" of a violation of federal criminal laws involving fraud, conflict of interest, bribery or improper gratuity, a violation of the civil U.S. False Claims Act or receipt of a significant overpayment from the government. Failure to make required disclosures could be a basis for suspension and/or debarment from federal government contracting in addition to breach of the specific contract and could also impact contracting beyond the U.S. federal level. Reported matters also could lead to audits or investigations and other civil, criminal or administrative sanctions.
|
•
|
Government contracts are subject to heightened reputational and contractual risks compared to contracts with commercial clients. For example, government contracts and the proceedings surrounding them are often subject to more extensive scrutiny and publicity. Negative publicity, including allegations of improper or illegal activity, poor contract performance, deficiencies in services or other deliverables, or information security breaches, regardless of accuracy, may adversely affect our reputation.
|
•
|
Terms and conditions of government contracts also tend to be more onerous and are often more difficult to negotiate. Because government contracts are subject to specific procurement regulations and a variety of other socio-economic requirements, we must comply with such requirements. We must also comply with various statutes, regulations and requirements related to employment practices, recordkeeping and accounting. These regulations and requirements
|
•
|
Government entities typically fund projects through appropriated monies. While these projects are often planned and executed as multi-year projects, government entities usually reserve the right to change the scope of projects or terminate these projects at their convenience either for lack of approved funding or any other reason. Changes in government or political developments, including budget deficits, shortfalls or uncertainties, government spending reductions (e.g., U.S. Congressional sequestration of funds under the Budget Control Act of 2011) or other debt constraints could result in our projects being reduced in price or scope or terminated altogether, which also could limit our recovery of reimbursable expenses. Furthermore, if insufficient funding is appropriated to the government entity to cover termination costs, we may not be able to fully recover our investments.
|
•
|
Our failure to comply with a variety of complex procurement rules and regulations could result in our being liable for penalties, including termination of our government contracts, disqualification from bidding on future government contracts and suspension or debarment from government contracting. We must comply with laws and regulations relating to the formation, administration and performance of government contracts, which affect how we do business with our customers and may impose added costs on our business. Significant statutes and regulations in the U.S. that we must comply with include the Federal Acquisition Regulation and supplements, the Truth in Negotiations Act, the Procurement Integrity Act, and the Civil False Claims Act.
|
•
|
Government contracts may be protested by unsuccessful bidders. These protests could result in administrative procedures and litigation, could be expensive to defend and incapable of prompt resolution. Loss of a bid protest may result in loss of the award, contract modification, expense or delay.
|
|
2018
|
|
2017
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
High
|
|
Low
|
|
Last
|
|
High
|
|
Low
|
|
Last
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
First Quarter
|
$
|
73.43
|
|
|
$
|
56.49
|
|
|
$
|
58.00
|
|
|
$
|
59.83
|
|
|
$
|
47.09
|
|
|
$
|
58.85
|
|
Second Quarter
|
63.22
|
|
|
52.05
|
|
|
59.79
|
|
|
69.28
|
|
|
58.09
|
|
|
66.47
|
|
||||||
Third Quarter
|
67.57
|
|
|
59.49
|
|
|
64.41
|
|
|
72.27
|
|
|
61.53
|
|
|
71.32
|
|
||||||
Fourth Quarter
|
65.44
|
|
|
48.78
|
|
|
52.01
|
|
|
73.86
|
|
|
62.86
|
|
|
67.39
|
|
|
|
Total Number of Shares Purchased (a)
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (b)
|
||||||
Period
|
|
|
|
|
||||||||||
September 30, 2018 - October 27, 2018
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
581,522,399
|
|
October 28, 2018 - November 24, 2018
|
|
1,722,734
|
|
|
58.05
|
|
|
1,722,124
|
|
|
481,556,844
|
|
||
November 25, 2018 - December 29, 2018
|
|
3,745,917
|
|
|
52.96
|
|
|
3,745,917
|
|
|
283,172,767
|
|
||
Total
|
|
5,468,651
|
|
|
$
|
54.56
|
|
|
5,468,041
|
|
|
|
(a)
|
Of the 5,468,651 shares of common stock, par value $0.01 per share, presented in the table above, 610 shares were originally granted to employees as restricted stock pursuant to our 2011 Omnibus Equity Incentive Plan (the "Omnibus Plan"). The Omnibus Plan allows for the withholding of shares to satisfy the minimum tax obligations due upon the vesting of restricted stock. Pursuant to the Omnibus Plan, the 610 shares reflected above were relinquished by employees in exchange for our agreement to pay U.S. federal and state withholding obligations resulting from the vesting of the Company's restricted stock.
|
(b)
|
As announced on May 25, 2017, our Board of Directors authorized a share repurchase program that allows the Company to repurchase up to
$500 million
of shares of our common stock, excluding transaction costs. As announced on May 21, 2018, our Board of Directors approved an amendment to the repurchase program that was authorized in May 2017. Under the amendment, the Company was authorized to repurchase up to an additional
$500 million
of shares of our common stock, for an aggregate of
$1 billion
, excluding transaction costs. The repurchases are to be effectuated in the open market, by block purchase, in privately negotiated transactions, or through other transactions managed by broker-dealers. No time limit was set for the completion of the program. During 2018, we repurchased
11.2 million
shares for total consideration of
$644 million
under the program pursuant to Rule 10b5-1 plans. At December 29, 2018,
$283 million
remains available for repurchase under the outstanding program. Refer to Note (14) of the notes to consolidated financial statements for further information regarding our share repurchase program.
|
(In thousands, except per share data)
|
2018
(1)
|
|
2017
(2)
|
|
2016
|
|
2015
(3)
|
|
2014
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenues
|
$
|
5,366,325
|
|
|
$
|
5,142,272
|
|
|
$
|
4,796,473
|
|
|
$
|
4,425,267
|
|
|
$
|
3,402,703
|
|
Operating earnings
|
774,785
|
|
|
960,471
|
|
|
911,013
|
|
|
781,136
|
|
|
763,084
|
|
|||||
Earnings before income taxes
|
800,851
|
|
|
967,129
|
|
|
918,434
|
|
|
781,380
|
|
|
774,174
|
|
|||||
Net earnings
|
630,059
|
|
|
866,978
|
|
|
636,484
|
|
|
539,362
|
|
|
525,433
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Earnings per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
1.91
|
|
|
2.62
|
|
|
1.88
|
|
|
1.57
|
|
|
1.54
|
|
|||||
Diluted
|
1.89
|
|
|
2.57
|
|
|
1.85
|
|
|
1.54
|
|
|
1.50
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
330,084
|
|
|
331,373
|
|
|
337,740
|
|
|
343,178
|
|
|
342,150
|
|
|||||
Diluted
|
333,572
|
|
|
337,999
|
|
|
343,653
|
|
|
350,908
|
|
|
350,386
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Working capital
|
$
|
1,356,114
|
|
|
$
|
1,590,632
|
|
|
$
|
773,960
|
|
|
$
|
1,049,967
|
|
|
$
|
1,714,471
|
|
Total assets
|
6,708,636
|
|
|
6,469,311
|
|
|
5,629,963
|
|
|
5,561,984
|
|
|
4,530,565
|
|
|||||
Long-term debt and capital lease obligations, excl. current installments
|
438,802
|
|
|
515,130
|
|
|
537,552
|
|
|
563,353
|
|
|
62,868
|
|
|||||
Shareholders' equity
|
4,928,389
|
|
|
4,785,348
|
|
|
3,927,947
|
|
|
3,870,384
|
|
|
3,565,968
|
|
(1)
|
In 2018, we adopted new revenue recognition guidance as further discussed in Note (2) of the notes to consolidated financial statements.
|
(2)
|
Includes the impact of certain U.S. income tax reform, as further described in Note (12) of the notes to consolidated financial statements.
|
(3)
|
In 2015, we acquired our Health Services business from Siemens AG.
|
(In thousands)
|
2018
|
% of
Revenue
|
|
2017
|
|
% of
Revenue
|
|
% Change
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||
Revenues
|
$
|
5,366,325
|
|
100
|
%
|
|
$
|
5,142,272
|
|
|
100
|
%
|
|
4
|
%
|
Costs of revenue
|
937,348
|
|
17
|
%
|
|
854,091
|
|
|
17
|
%
|
|
10
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Margin
|
4,428,977
|
|
83
|
%
|
|
4,288,181
|
|
|
83
|
%
|
|
3
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses
|
|
|
|
|
|
|
|
|
|||||||
Sales and client service
|
2,493,696
|
|
46
|
%
|
|
2,276,821
|
|
|
44
|
%
|
|
10
|
%
|
||
Software development
|
683,663
|
|
13
|
%
|
|
605,046
|
|
|
12
|
%
|
|
13
|
%
|
||
General and administrative
|
389,469
|
|
7
|
%
|
|
355,267
|
|
|
7
|
%
|
|
10
|
%
|
||
Amortization of acquisition-related intangibles
|
87,364
|
|
2
|
%
|
|
90,576
|
|
|
2
|
%
|
|
(4
|
)%
|
||
|
|
|
|
|
|
|
|
|
|
||||||
Total operating expenses
|
3,654,192
|
|
68
|
%
|
|
3,327,710
|
|
|
65
|
%
|
|
10
|
%
|
||
|
|
|
|
|
|
|
|
|
|
||||||
Total costs and expenses
|
4,591,540
|
|
86
|
%
|
|
4,181,801
|
|
|
81
|
%
|
|
10
|
%
|
||
|
|
|
|
|
|
|
|
|
|
||||||
Operating earnings
|
774,785
|
|
14
|
%
|
|
960,471
|
|
|
19
|
%
|
|
(19
|
)%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Other income, net
|
26,066
|
|
|
|
6,658
|
|
|
|
|
|
|||||
Income taxes
|
(170,792
|
)
|
|
|
(100,151
|
)
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||
Net earnings
|
$
|
630,059
|
|
|
|
$
|
866,978
|
|
|
|
|
(27
|
)%
|
•
|
Sales and client service expenses as a percent of revenues were
46%
in
2018
, compared to
44%
in
2017
. These expenses increased
10%
to
$2.49 billion
in
2018
, from
$2.28 billion
in
2017
. Sales and client service expenses include salaries and benefits of sales, marketing, support, and services personnel, depreciation and other expenses associated with our managed services business, communications expenses, unreimbursed travel expenses, expense for share-based payments, and trade show and advertising costs. The 2018 amount includes a pre-tax charge of $45 million to provide an allowance against certain client receivables with Fujitsu Services Limited ("Fujitsu"), as further discussed in Note (3) of the notes to consolidated financial statements. The remaining growth in sales and client service expenses is primarily due to the hiring of services personnel to support growth in services revenue.
|
•
|
Software development expenses as a percent of revenues were
13%
in
2018
, compared to
12%
in
2017
. Expenditures for software development include ongoing development and enhancement of the
Cerner Millennium
®
and
HealtheIntent
platforms, with a focus on supporting key initiatives to enhance physician experience, revenue cycle and population health solutions. A summary of our total software development expense in
2018
and
2017
is as follows:
|
|
For the Years Ended
|
||||||
(In thousands)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Software development costs
|
$
|
747,128
|
|
|
$
|
705,944
|
|
Capitalized software costs
|
(271,787
|
)
|
|
(271,411
|
)
|
||
Capitalized costs related to share-based payments
|
(1,906
|
)
|
|
(2,737
|
)
|
||
Amortization of capitalized software costs
|
210,228
|
|
|
173,250
|
|
||
|
|
|
|
||||
Total software development expense
|
$
|
683,663
|
|
|
$
|
605,046
|
|
•
|
General and administrative expenses as a percent of revenues were
7%
in both
2018
and
2017
. These expenses increased
10%
to
$389 million
in
2018
, from
$355 million
in
2017
. General and administrative expenses include
|
•
|
Amortization of acquisition-related intangibles as a percent of revenues was
2%
in both
2018
and
2017
. These expenses decreased
4%
to
$87 million
in
2018
, from
$91 million
in
2017
. Amortization of acquisition-related intangibles includes the amortization of customer relationships, acquired technology, trade names, and non-compete agreements recorded in connection with our business acquisitions. The decrease in amortization of acquisition-related intangibles includes the impact of certain intangible assets becoming fully amortized.
|
•
|
Other income, net was
$26 million
in
2018
, compared to
$7 million
in
2017
. The increase is primarily attributable to increased interest on our cash and investment balances, due to rising interest rates.
|
•
|
Our effective tax rate was
21%
in
2018
, compared to
10%
in
2017
. The increase in the effective tax rate in
2018
is primarily a result of impacts from certain U.S. income tax reform enacted in December 2017. Refer to Note (12) of the notes to consolidated financial statements for further information regarding our effective tax rate. We do not expect significant changes to our overall effective tax rate in 2019, from what is reported for 2018.
|
(In thousands)
|
2018
|
|
% of Segment Revenue
|
|
2017
|
|
% of Segment Revenue
|
|
% Change
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Domestic Segment
|
|
|
|
|
|
|
|
|
|
||||
Revenues
|
$
|
4,730,266
|
|
|
100%
|
|
$
|
4,575,171
|
|
|
100%
|
|
3%
|
Costs of revenue
|
827,904
|
|
|
18%
|
|
755,729
|
|
|
17%
|
|
10%
|
||
Operating expenses
|
2,164,465
|
|
|
46%
|
|
1,998,544
|
|
|
44%
|
|
8%
|
||
Total costs and expenses
|
2,992,369
|
|
|
63%
|
|
2,754,273
|
|
|
60%
|
|
9%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Domestic operating earnings
|
1,737,897
|
|
|
37%
|
|
1,820,898
|
|
|
40%
|
|
(5)%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Global Segment
|
|
|
|
|
|
|
|
|
|
||||
Revenues
|
636,059
|
|
|
100%
|
|
567,101
|
|
|
100%
|
|
12%
|
||
Costs of revenue
|
109,444
|
|
|
17%
|
|
98,362
|
|
|
17%
|
|
11%
|
||
Operating expenses
|
321,116
|
|
|
50%
|
|
264,196
|
|
|
47%
|
|
22%
|
||
Total costs and expenses
|
430,560
|
|
|
68%
|
|
362,558
|
|
|
64%
|
|
19%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Global operating earnings
|
205,499
|
|
|
32%
|
|
204,543
|
|
|
36%
|
|
—%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Other, net
|
(1,168,611
|
)
|
|
|
|
(1,064,970
|
)
|
|
|
|
10%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Consolidated operating earnings
|
$
|
774,785
|
|
|
|
|
$
|
960,471
|
|
|
|
|
(19)%
|
•
|
Revenues increased
3%
to
$4.73 billion
in
2018
, from
$4.58 billion
in
2017
. The growth in revenues includes a $181 million increase in professional services revenue, driven by increased contributions from
Cerner ITWorks
|
•
|
Costs of revenue as a percent of revenues were
18%
in
2018
, compared to
17%
in
2017
. The higher costs of revenue as a percent of revenues was primarily driven by higher third-party costs associated with services revenue.
|
•
|
Operating expenses as a percent of revenues were
46%
in
2018
, compared to
44%
in
2017
. The higher operating expenses as a percent of revenues reflects the hiring of personnel to support revenue growth.
|
•
|
Revenues increased
12%
to
$636 million
in
2018
, from
$567 million
in
2017
. This increase was driven by growth across most of our business. Refer to Note (2) of the notes to consolidated financial statements for further information regarding revenues disaggregated by our business models.
|
•
|
Costs of revenue as a percent of revenues were
17%
in both
2018
and
2017
.
|
•
|
Operating expenses as a percent of revenues were
50%
in
2018
, compared to
47%
in
2017
. The increase as a percent of revenues is primarily due to a pre-tax charge of $45 million in
2018
to provide an allowance against certain client receivables with Fujitsu, as further discussed in Note (3) of the notes to consolidated financial statements.
|
(In thousands)
|
2017
|
% of
Revenue
|
|
2016
|
|
% of
Revenue
|
|
% Change
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||
Revenues
|
$
|
5,142,272
|
|
100
|
%
|
|
$
|
4,796,473
|
|
|
100
|
%
|
|
7
|
%
|
Costs of revenue
|
854,091
|
|
17
|
%
|
|
779,116
|
|
|
16
|
%
|
|
10
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Margin
|
4,288,181
|
|
83
|
%
|
|
4,017,357
|
|
|
84
|
%
|
|
7
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses
|
|
|
|
|
|
|
|
|
|||||||
Sales and client service
|
2,276,821
|
|
44
|
%
|
|
2,071,926
|
|
|
43
|
%
|
|
10
|
%
|
||
Software development
|
605,046
|
|
12
|
%
|
|
551,418
|
|
|
11
|
%
|
|
10
|
%
|
||
General and administrative
|
355,267
|
|
7
|
%
|
|
392,454
|
|
|
8
|
%
|
|
(9
|
)%
|
||
Amortization of acquisition-related intangibles
|
90,576
|
|
2
|
%
|
|
90,546
|
|
|
2
|
%
|
|
—
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Total operating expenses
|
3,327,710
|
|
65
|
%
|
|
3,106,344
|
|
|
65
|
%
|
|
7
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Total costs and expenses
|
4,181,801
|
|
81
|
%
|
|
3,885,460
|
|
|
81
|
%
|
|
8
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Operating earnings
|
960,471
|
|
19
|
%
|
|
911,013
|
|
|
19
|
%
|
|
5
|
%
|
||
|
|
|
|
|
|
|
|
|
|||||||
Other income, net
|
6,658
|
|
|
|
7,421
|
|
|
|
|
|
|||||
Income taxes
|
(100,151
|
)
|
|
|
(281,950
|
)
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||
Net earnings
|
$
|
866,978
|
|
|
|
$
|
636,484
|
|
|
|
|
36
|
%
|
•
|
Sales and client service expenses as a percent of revenues were
44%
in
2017
, compared to
43%
in
2016
. These expenses increased
10%
to
$2.28 billion
in
2017
, from
$2.07 billion
in
2016
. The growth in sales and client service expenses reflects hiring of services personnel to support the growth in services revenue.
|
•
|
Software development expenses as a percent of revenues were
12%
in
2017
, compared to
11%
in
2016
. Expenditures for software development include ongoing development and enhancement of the
Cerner Millennium
®
and
HealtheIntent
platforms, with a focus on supporting key initiatives to enhance physician experience, revenue cycle and population health solutions. A summary of our total software development expense in
2017
and
2016
is as follows:
|
|
For the Years Ended
|
||||||
(In thousands)
|
2017
|
|
2016
|
||||
|
|
|
|
||||
Software development costs
|
$
|
705,944
|
|
|
$
|
704,882
|
|
Capitalized software costs
|
(271,411
|
)
|
|
(290,911
|
)
|
||
Capitalized costs related to share-based payments
|
(2,737
|
)
|
|
(2,785
|
)
|
||
Amortization of capitalized software costs
|
173,250
|
|
|
140,232
|
|
||
|
|
|
|
||||
Total software development expense
|
$
|
605,046
|
|
|
$
|
551,418
|
|
•
|
General and administrative expenses as a percent of revenues were
7%
in
2017
, compared to
8%
in
2016
. These expenses decreased
9%
to
$355 million
in
2017
, from
$392 million
in
2016
. The decrease in general and administrative expenses was primarily due to 2016 containing $36 million of expenses associated with a voluntary separation plan. Refer to Note (1) of the notes to consolidated financial statements for further detail regarding our 2016 voluntary separation plan.
|
•
|
Amortization of acquisition-related intangibles as a percent of revenues was
2%
in both
2017
and
2016
. These expenses remained flat at
$91 million
in both
2017
and
2016
.
|
•
|
Other income, net remained flat at
$7 million
in both
2017
and
2016
.
|
•
|
Our effective tax rate was
10%
in
2017
, compared to
31%
in
2016
. The decrease in the effective tax rate in
2017
is primarily a result of impacts from certain U.S. income tax reform enacted in December 2017, and the inclusion of net excess tax benefits as discrete items within the tax provision, upon our adoption of ASU 2016-09 in the first quarter of
2017
. Refer to Note (12) of the notes to consolidated financial statements for further information regarding our effective tax rate.
|
(In thousands)
|
2017
|
|
% of Segment Revenue
|
|
2016
|
|
% of Segment Revenue
|
|
% Change
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Domestic Segment
|
|
|
|
|
|
|
|
|
|
||||
Revenues
|
$
|
4,575,171
|
|
|
100%
|
|
$
|
4,245,097
|
|
|
100%
|
|
8%
|
Costs of revenue
|
755,729
|
|
|
17%
|
|
676,437
|
|
|
16%
|
|
12%
|
||
Operating expenses
|
1,998,544
|
|
|
44%
|
|
1,774,146
|
|
|
42%
|
|
13%
|
||
Total costs and expenses
|
2,754,273
|
|
|
60%
|
|
2,450,583
|
|
|
58%
|
|
12%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Domestic operating earnings
|
1,820,898
|
|
|
40%
|
|
1,794,514
|
|
|
42%
|
|
1%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Global Segment
|
|
|
|
|
|
|
|
|
|
||||
Revenues
|
567,101
|
|
|
100%
|
|
551,376
|
|
|
100%
|
|
3%
|
||
Costs of revenue
|
98,362
|
|
|
17%
|
|
102,679
|
|
|
19%
|
|
(4)%
|
||
Operating expenses
|
264,196
|
|
|
47%
|
|
246,243
|
|
|
45%
|
|
7%
|
||
Total costs and expenses
|
362,558
|
|
|
64%
|
|
348,922
|
|
|
63%
|
|
4%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Global operating earnings
|
204,543
|
|
|
36%
|
|
202,454
|
|
|
37%
|
|
1%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Other, net
|
(1,064,970
|
)
|
|
|
|
(1,085,955
|
)
|
|
|
|
(2)%
|
||
|
|
|
|
|
|
|
|
|
|
||||
Consolidated operating earnings
|
$
|
960,471
|
|
|
|
|
$
|
911,013
|
|
|
|
|
5%
|
•
|
Revenues increased
8%
to
$4.58 billion
in
2017
, from
$4.25 billion
in
2016
. The growth in revenues includes a $141 million increase in professional services revenue, driven by growth in implementation and consulting activities. Refer to Note (2) of the notes to consolidated financial statements for further information regarding revenues disaggregated by our business models.
|
•
|
Costs of revenue as a percent of revenues were
17%
in
2017
, compared to
16%
in
2016
. The marginally higher costs of revenue as a percent of revenues was primarily due to higher third-party costs associated with technology resale.
|
•
|
Operating expenses as a percent of revenues were
44%
in
2017
, compared to
42%
in
2016
. The increase as a percent of revenues reflects hiring of services personnel to support the growth in services revenue.
|
•
|
Revenues increased
3%
to
$567 million
in
2017
, from
$551 million
in
2016
. The growth in revenues includes a $13 million increase in support and maintenance revenue. Refer to Note (2) of the notes to consolidated financial statements for further information regarding revenues disaggregated by our business models.
|
•
|
Costs of revenue as a percent of revenues were
17%
in
2017
, compared to
19%
in
2016
. The lower costs of revenue as a percent of revenues was primarily driven by a lower mix of technology resale, which carries a higher cost of revenue.
|
•
|
Operating expenses as a percent of revenues were
47%
in
2017
, compared to
45%
in
2016
. The increase as a percent of revenues is primarily due to an increase in non-personnel expenses.
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Cash flows from operating activities
|
$
|
1,454,009
|
|
|
$
|
1,307,675
|
|
|
$
|
1,245,637
|
|
Cash flows from investing activities
|
(828,937
|
)
|
|
(1,005,851
|
)
|
|
(789,774
|
)
|
|||
Cash flows from financing activities
|
(609,787
|
)
|
|
(110,984
|
)
|
|
(676,677
|
)
|
|||
Effect of exchange rate changes on cash
|
(12,082
|
)
|
|
9,222
|
|
|
(10,447
|
)
|
|||
Total change in cash and cash equivalents
|
3,203
|
|
|
200,062
|
|
|
(231,261
|
)
|
|||
|
|
|
|
|
|
||||||
Cash and cash equivalents at beginning of period
|
370,923
|
|
|
170,861
|
|
|
402,122
|
|
|||
|
|
|
|
|
|
||||||
Cash and cash equivalents at end of period
|
$
|
374,126
|
|
|
$
|
370,923
|
|
|
$
|
170,861
|
|
|
|
|
|
|
|
||||||
Free cash flow (non-GAAP)
|
$
|
733,388
|
|
|
$
|
671,444
|
|
|
$
|
492,514
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Cash collections from clients
|
$
|
5,486,654
|
|
|
$
|
5,444,531
|
|
|
$
|
5,184,252
|
|
Cash paid to employees and suppliers and other
|
(4,032,498
|
)
|
|
(3,932,398
|
)
|
|
(3,665,592
|
)
|
|||
Cash paid for interest
|
(15,707
|
)
|
|
(17,914
|
)
|
|
(18,484
|
)
|
|||
Cash paid for taxes, net of refunds
|
15,560
|
|
|
(186,544
|
)
|
|
(254,539
|
)
|
|||
|
|
|
|
|
|
||||||
Total cash from operations
|
$
|
1,454,009
|
|
|
$
|
1,307,675
|
|
|
$
|
1,245,637
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Capital purchases
|
$
|
(446,928
|
)
|
|
$
|
(362,083
|
)
|
|
$
|
(459,427
|
)
|
Capitalized software development costs
|
(273,693
|
)
|
|
(274,148
|
)
|
|
(293,696
|
)
|
|||
Purchases of investments, net of sales and maturities
|
(71,497
|
)
|
|
(339,974
|
)
|
|
(18,179
|
)
|
|||
Purchase of other intangibles
|
(36,819
|
)
|
|
(29,646
|
)
|
|
(18,472
|
)
|
|||
|
|
|
|
|
|
||||||
Total cash flows from investing activities
|
$
|
(828,937
|
)
|
|
$
|
(1,005,851
|
)
|
|
$
|
(789,774
|
)
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Repayment of long-term debt
|
$
|
(75,000
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Cash from option exercises (net of taxes paid in connection with shares surrendered by associates)
|
81,476
|
|
|
65,121
|
|
|
25,672
|
|
|||
Treasury stock purchases
|
(623,127
|
)
|
|
(173,434
|
)
|
|
(700,275
|
)
|
|||
Contingent consideration payments for acquisition of businesses
|
(1,691
|
)
|
|
(2,671
|
)
|
|
(2,074
|
)
|
|||
Other
|
8,555
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
||||||
Total cash flows from financing activities
|
$
|
(609,787
|
)
|
|
$
|
(110,984
|
)
|
|
$
|
(676,677
|
)
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Cash flows from operating activities (GAAP)
|
$
|
1,454,009
|
|
|
$
|
1,307,675
|
|
|
$
|
1,245,637
|
|
Capital purchases
|
(446,928
|
)
|
|
(362,083
|
)
|
|
(459,427
|
)
|
|||
Capitalized software development costs
|
(273,693
|
)
|
|
(274,148
|
)
|
|
(293,696
|
)
|
|||
|
|
|
|
|
|
||||||
Free cash flow (non-GAAP)
|
$
|
733,388
|
|
|
$
|
671,444
|
|
|
$
|
492,514
|
|
|
Payments Due by Period
|
||||||||||||||||||||||||||
(In thousands)
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
2024 and thereafter
|
|
Total
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Balance sheet obligations
(a)
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Long-term debt obligations
|
$
|
—
|
|
|
$
|
2,500
|
|
|
$
|
—
|
|
|
$
|
226,100
|
|
|
$
|
1,700
|
|
|
$
|
208,862
|
|
|
$
|
439,162
|
|
Interest on long-term debt obligations
|
14,315
|
|
|
14,315
|
|
|
14,315
|
|
|
10,738
|
|
|
7,160
|
|
|
10,740
|
|
|
71,583
|
|
|||||||
Capital lease obligations
|
4,914
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,914
|
|
|||||||
Interest on capital lease obligations
|
143
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
143
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Other obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Operating lease obligations
|
29,739
|
|
|
27,669
|
|
|
22,904
|
|
|
17,240
|
|
|
10,166
|
|
|
17,743
|
|
|
125,461
|
|
|||||||
Purchase obligations
|
138,851
|
|
|
102,773
|
|
|
24,746
|
|
|
15,517
|
|
|
15,486
|
|
|
26,924
|
|
|
324,297
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Total
|
$
|
187,962
|
|
|
$
|
147,257
|
|
|
$
|
61,965
|
|
|
$
|
269,595
|
|
|
$
|
34,512
|
|
|
$
|
264,269
|
|
|
$
|
965,560
|
|
a)
|
Evaluation of Disclosure Controls and Procedures.
|
b)
|
Management's Report on Internal Control over Financial Reporting.
|
c)
|
Changes in Internal Control over Financial Reporting.
|
•
|
The gathering of information and evaluation of analysis used in the development of disclosures required prior to the new standard's adoption.
|
d)
|
Limitations on Controls.
|
(In thousands, except per share data)
|
Securities to be issued upon exercise of outstanding options and rights
(1)
|
|
Weighted average exercise price per share
(2)
|
|
Securities available for future issuance
(3)
|
||||
Plan category
|
|
|
|||||||
|
|
|
|
|
|
||||
Equity compensation plans approved by security holders
(4)
|
22,674
|
|
|
$
|
52.31
|
|
|
7,400
|
|
Equity compensation plans not approved by security holders
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
||||
Total
|
22,674
|
|
|
|
|
7,400
|
|
a)
|
Financial Statements and Exhibits
|
(1)
|
Consolidated Financial Statements:
|
(2)
|
Financial Statement Schedules
|
b)
|
Exhibits
|
|
|
|
|
Incorporated by Reference
|
|
|
||||
Exhibit Number
|
|
Exhibit Description
|
|
Form
|
|
Exhibit(s)
|
|
Filing Date
SEC File No./Film No.
|
|
Filed Herewith
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
|
10-K
|
|
3(a)
|
|
2/11/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
|
8-K
|
|
3.1
|
|
3/6/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
10-K
|
|
4(a)
|
|
2/28/2007
000-15386/07658265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1*
|
|
|
10-K
|
|
10(a)
|
|
2/28/2007
000-15386/07658265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2*
|
|
|
8-K
|
|
99.1
|
|
6/3/2010
000-15386/10875957
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.3*
|
|
|
10-K
|
|
10.3
|
|
2/12/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4*
|
|
|
10-Q
|
|
10.2
|
|
5/3/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.5*
|
|
|
10-Q
|
|
10.1
|
|
10/26/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.6*
|
|
|
8-K/A
|
|
10.1
|
|
8/17/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7*
|
|
|
8-K
|
|
10.1
|
|
9/11/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.8*
|
|
|
10-Q
|
|
10.2
|
|
10/26/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9*
|
|
|
8-K
|
|
10.2
|
|
9/11/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10*
|
|
|
8-K
|
|
10.3
|
|
9/11/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11*
|
|
|
10-Q
|
|
10.10
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12*
|
|
|
8-K
|
|
10.4
|
|
9/11/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13*
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.14*
|
|
|
10-K
|
|
10(f)
|
|
3/30/2001
000-15386/1586224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.15*
|
|
|
10-K
|
|
10(g)
|
|
3/30/2001
000-15386/1586224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.16*
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.17*
|
|
|
DEF 14A
|
|
Annex I
|
|
4/16/2001
000-15386/1603080
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.18*
|
|
|
10-K
|
|
10(v)
|
|
3/17/2005
000-15386/05688830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.19*
|
|
|
10-Q
|
|
10(a)
|
|
11/10/2005
000-15386/051193974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.20*
|
|
|
10-K
|
|
10(g)
|
|
2/27/2008
000-15386/08646565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.21*
|
|
|
10-K
|
|
10(q)
|
|
2/27/2008
000-15386/08646565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.22*
|
|
|
8-K
|
|
10.2
|
|
5/27/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.23*
|
|
|
10-Q
|
|
10.2
|
|
5/6/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.24*
|
|
|
10-K
|
|
10(u)
|
|
2/8/2013
000-15386/13586825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.25*
|
|
|
10-Q
|
|
10.3
|
|
5/6/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.26*
|
|
|
10-Q
|
|
10.4
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.27*
|
|
|
10-Q
|
|
10.4
|
|
5/6/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.28*
|
|
|
10-Q
|
|
10.3
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.29*
|
|
|
10-K
|
|
10(v)
|
|
2/8/2013
000-15386/13586825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.30*
|
|
|
10-Q
|
|
10.5
|
|
5/6/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.31*
|
|
|
10-Q
|
|
10.2
|
|
8/3/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.32*
|
|
|
10-Q
|
|
10.2
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.33*
|
|
|
10-Q
|
|
10.2
|
|
4/28/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.34*
|
|
|
10-Q
|
|
10.5
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.35*
|
|
|
10-Q
|
|
10.3
|
|
4/28/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.36*
|
|
|
10-Q
|
|
10.6
|
|
10/27/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.37*
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.38*
|
|
|
8-K
|
|
10.1
|
|
3/6/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.39*
|
|
|
8-K
|
|
10.2
|
|
3/6/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.40
|
|
|
8-K
|
|
99.1
|
|
1/25/2010
000-15386/10543089
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.41
|
|
|
10-Q
|
|
2.1
|
|
10/24/2014
000-15386/141172425
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.42
|
|
|
8-K
|
|
10.1
|
|
2/2/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.43
|
|
|
8-K
|
|
10.1
|
|
12/5/2014
000-15386/141269611
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.44
|
|
|
8-K
|
|
10.1
|
|
11/3/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
CERNER CORPORATION
|
|
|
|
|
|
Date: February 8, 2019
|
|
By:
|
/s/ Brent Shafer
|
|
|
|
D. Brent Shafer
|
|
|
|
Chairman of the Board and
|
|
|
|
Chief Executive Officer
|
Signature and Title
|
|
Date
|
|
|
|
/s/ Brent Shafer
|
|
February 8, 2019
|
Brent Shafer, Chairman of the Board and Chief Executive Officer (Principal Executive Officer)
|
|
|
|
|
|
/s/ Marc G. Naughton
|
|
February 8, 2019
|
Marc G. Naughton, Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
|
/s/ Michael R. Battaglioli
|
|
February 8, 2019
|
Michael R. Battaglioli, Vice President and
Chief Accounting Officer (Principal Accounting Officer)
|
|
|
|
|
|
/s/ Gerald E. Bisbee, Jr.
|
|
February 8, 2019
|
Gerald E. Bisbee, Jr., Ph.D., Director
|
|
|
|
|
|
/s/ Denis A. Cortese
|
|
February 8, 2019
|
Denis A. Cortese, M.D., Director
|
|
|
|
|
|
/s/ Mitchell E. Daniels
|
|
February 8, 2019
|
Mitchell E. Daniels, Director
|
|
|
|
|
|
/s/ Linda M. Dillman
|
|
February 8, 2019
|
Linda M. Dillman, Director
|
|
|
|
|
|
/s/ Julie L. Gerberding
|
|
February 8, 2019
|
Julie L. Gerberding, M.D., Director
|
|
|
|
|
|
/s/ William D. Zollars
|
|
February 8, 2019
|
William D. Zollars, Director
|
|
|
(In thousands, except share data)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
374,126
|
|
|
$
|
370,923
|
|
Short-term investments
|
401,285
|
|
|
434,844
|
|
||
Receivables, net
|
1,183,494
|
|
|
1,042,781
|
|
||
Inventory
|
25,029
|
|
|
15,749
|
|
||
Prepaid expenses and other
|
334,870
|
|
|
515,930
|
|
||
Total current assets
|
2,318,804
|
|
|
2,380,227
|
|
||
|
|
|
|
||||
Property and equipment, net
|
1,743,575
|
|
|
1,603,319
|
|
||
Software development costs, net
|
894,512
|
|
|
822,159
|
|
||
Goodwill
|
847,544
|
|
|
853,005
|
|
||
Intangible assets, net
|
405,305
|
|
|
479,753
|
|
||
Long-term investments
|
300,046
|
|
|
196,837
|
|
||
Other assets
|
198,850
|
|
|
134,011
|
|
||
|
|
|
|
||||
Total assets
|
$
|
6,708,636
|
|
|
$
|
6,469,311
|
|
|
|
|
|
||||
Liabilities and Shareholders’ Equity
|
|
|
|
||||
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
293,534
|
|
|
$
|
218,996
|
|
Current installments of long-term debt and capital lease obligations
|
4,914
|
|
|
11,585
|
|
||
Deferred revenue
|
399,189
|
|
|
311,337
|
|
||
Accrued payroll and tax withholdings
|
195,931
|
|
|
183,770
|
|
||
Other accrued expenses
|
69,122
|
|
|
63,907
|
|
||
Total current liabilities
|
962,690
|
|
|
789,595
|
|
||
|
|
|
|
||||
Long-term debt and capital lease obligations
|
438,802
|
|
|
515,130
|
|
||
Deferred income taxes
|
336,379
|
|
|
336,446
|
|
||
Other liabilities
|
42,376
|
|
|
42,792
|
|
||
Total liabilities
|
1,780,247
|
|
|
1,683,963
|
|
||
|
|
|
|
||||
Shareholders’ Equity:
|
|
|
|
||||
Common stock, $.01 par value, 500,000,000 shares authorized, 362,212,843 shares issued at December 29, 2018 and 359,204,864 shares issued at December 30, 2017
|
3,622
|
|
|
3,592
|
|
||
Additional paid-in capital
|
1,559,562
|
|
|
1,380,371
|
|
||
Retained earnings
|
5,576,525
|
|
|
4,938,866
|
|
||
Treasury stock, 37,905,013 shares at December 29, 2018 and 26,743,517 shares at December 30, 2017
|
(2,107,768
|
)
|
|
(1,464,099
|
)
|
||
Accumulated other comprehensive loss, net
|
(103,552
|
)
|
|
(73,382
|
)
|
||
Total shareholders’ equity
|
4,928,389
|
|
|
4,785,348
|
|
||
|
|
|
|
||||
Total liabilities and shareholders’ equity
|
$
|
6,708,636
|
|
|
$
|
6,469,311
|
|
|
For the Years Ended
|
||||||||||
(In thousands, except per share data)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Revenues
|
$
|
5,366,325
|
|
|
$
|
5,142,272
|
|
|
$
|
4,796,473
|
|
Costs and expenses:
|
|
|
|
|
|
||||||
Costs of revenue
|
937,348
|
|
|
854,091
|
|
|
779,116
|
|
|||
Sales and client service
|
2,493,696
|
|
|
2,276,821
|
|
|
2,071,926
|
|
|||
Software development (Includes amortization of $210,228, $173,250 and $140,232, respectively)
|
683,663
|
|
|
605,046
|
|
|
551,418
|
|
|||
General and administrative
|
389,469
|
|
|
355,267
|
|
|
392,454
|
|
|||
Amortization of acquisition-related intangibles
|
87,364
|
|
|
90,576
|
|
|
90,546
|
|
|||
|
|
|
|
|
|
||||||
Total costs and expenses
|
4,591,540
|
|
|
4,181,801
|
|
|
3,885,460
|
|
|||
|
|
|
|
|
|
||||||
Operating earnings
|
774,785
|
|
|
960,471
|
|
|
911,013
|
|
|||
|
|
|
|
|
|
||||||
Other income, net
|
26,066
|
|
|
6,658
|
|
|
7,421
|
|
|||
|
|
|
|
|
|
||||||
Earnings before income taxes
|
800,851
|
|
|
967,129
|
|
|
918,434
|
|
|||
Income taxes
|
(170,792
|
)
|
|
(100,151
|
)
|
|
(281,950
|
)
|
|||
|
|
|
|
|
|
||||||
Net earnings
|
$
|
630,059
|
|
|
$
|
866,978
|
|
|
$
|
636,484
|
|
|
|
|
|
|
|
||||||
Basic earnings per share
|
$
|
1.91
|
|
|
$
|
2.62
|
|
|
$
|
1.88
|
|
Diluted earnings per share
|
$
|
1.89
|
|
|
$
|
2.57
|
|
|
$
|
1.85
|
|
Basic weighted average shares outstanding
|
330,084
|
|
|
331,373
|
|
|
337,740
|
|
|||
Diluted weighted average shares outstanding
|
333,572
|
|
|
337,999
|
|
|
343,653
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Net earnings
|
$
|
630,059
|
|
|
$
|
866,978
|
|
|
$
|
636,484
|
|
Foreign currency translation adjustment and other (net of taxes (benefit) of $(645), $4,909 and $2,092, respectively)
|
(30,575
|
)
|
|
37,463
|
|
|
(33,871
|
)
|
|||
Unrealized holding gain (loss) on available-for-sale investments (net of taxes (benefit) of $132, $(416) and $37, respectively)
|
405
|
|
|
(680
|
)
|
|
60
|
|
|||
|
|
|
|
|
|
||||||
Comprehensive income
|
$
|
599,889
|
|
|
$
|
903,761
|
|
|
$
|
602,673
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
||||||
Net earnings
|
$
|
630,059
|
|
|
$
|
866,978
|
|
|
$
|
636,484
|
|
Adjustments to reconcile net earnings to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Depreciation and amortization
|
642,591
|
|
|
580,723
|
|
|
504,236
|
|
|||
Share-based compensation expense
|
95,423
|
|
|
83,019
|
|
|
74,536
|
|
|||
Provision for deferred income taxes
|
34,428
|
|
|
47,409
|
|
|
(11,517
|
)
|
|||
Changes in assets and liabilities:
|
|
|
|
|
|
||||||
Receivables, net
|
(207,785
|
)
|
|
(32,836
|
)
|
|
78,258
|
|
|||
Inventory
|
(9,307
|
)
|
|
(972
|
)
|
|
(666
|
)
|
|||
Prepaid expenses and other
|
156,216
|
|
|
(191,369
|
)
|
|
(66,658
|
)
|
|||
Accounts payable
|
65,202
|
|
|
6,960
|
|
|
(13,197
|
)
|
|||
Accrued income taxes
|
(27,849
|
)
|
|
18,358
|
|
|
64,073
|
|
|||
Deferred revenue
|
81,538
|
|
|
(3,114
|
)
|
|
1,555
|
|
|||
Other accrued liabilities
|
(6,507
|
)
|
|
(67,481
|
)
|
|
(21,467
|
)
|
|||
|
|
|
|
|
|
||||||
Net cash provided by operating activities
|
1,454,009
|
|
|
1,307,675
|
|
|
1,245,637
|
|
|||
|
|
|
|
|
|
||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||||||
Capital purchases
|
(446,928
|
)
|
|
(362,083
|
)
|
|
(459,427
|
)
|
|||
Capitalized software development costs
|
(273,693
|
)
|
|
(274,148
|
)
|
|
(293,696
|
)
|
|||
Purchases of investments
|
(623,293
|
)
|
|
(632,048
|
)
|
|
(482,078
|
)
|
|||
Sales and maturities of investments
|
551,796
|
|
|
292,074
|
|
|
463,899
|
|
|||
Purchase of other intangibles
|
(36,819
|
)
|
|
(29,646
|
)
|
|
(18,472
|
)
|
|||
|
|
|
|
|
|
||||||
Net cash used in investing activities
|
(828,937
|
)
|
|
(1,005,851
|
)
|
|
(789,774
|
)
|
|||
|
|
|
|
|
|
||||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
||||||
Repayment of long-term debt
|
(75,000
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from exercise of stock options
|
91,349
|
|
|
76,705
|
|
|
63,794
|
|
|||
Payments to taxing authorities in connection with shares directly withheld from associates
|
(9,873
|
)
|
|
(11,584
|
)
|
|
(38,122
|
)
|
|||
Treasury stock purchases
|
(623,127
|
)
|
|
(173,434
|
)
|
|
(700,275
|
)
|
|||
Contingent consideration payments for acquisition of businesses
|
(1,691
|
)
|
|
(2,671
|
)
|
|
(2,074
|
)
|
|||
Other
|
8,555
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
||||||
Net cash used in financing activities
|
(609,787
|
)
|
|
(110,984
|
)
|
|
(676,677
|
)
|
|||
|
|
|
|
|
|
||||||
Effect of exchange rate changes on cash and cash equivalents
|
(12,082
|
)
|
|
9,222
|
|
|
(10,447
|
)
|
|||
|
|
|
|
|
|
||||||
Net increase (decrease) in cash and cash equivalents
|
3,203
|
|
|
200,062
|
|
|
(231,261
|
)
|
|||
Cash and cash equivalents at beginning of period
|
370,923
|
|
|
170,861
|
|
|
402,122
|
|
|||
|
|
|
|
|
|
||||||
Cash and cash equivalents at end of period
|
$
|
374,126
|
|
|
$
|
370,923
|
|
|
$
|
170,861
|
|
|
Common Stock
|
|
Additional
|
|
Retained
|
|
Treasury
|
|
Accumulated Other
|
|||||||||||||
(In thousands)
|
Shares
|
|
Amount
|
|
Paid-in Capital
|
|
Earnings
|
|
Stock
|
|
Comprehensive Loss, Net
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at January 2, 2016
|
350,323
|
|
|
$
|
3,503
|
|
|
$
|
1,075,782
|
|
|
$
|
3,457,843
|
|
|
$
|
(590,390
|
)
|
|
$
|
(76,354
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Exercise of stock options (including net-settled option exercises)
|
3,408
|
|
|
34
|
|
|
27,747
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Employee share-based compensation expense
|
—
|
|
|
—
|
|
|
74,536
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Employee share-based compensation net excess tax benefit
|
—
|
|
|
—
|
|
|
52,848
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(33,811
|
)
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Treasury stock purchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(700,275
|
)
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
636,484
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at December 31, 2016
|
353,731
|
|
|
3,537
|
|
|
1,230,913
|
|
|
4,094,327
|
|
|
(1,290,665
|
)
|
|
(110,165
|
)
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Exercise of stock options (including net-settled option exercises)
|
5,474
|
|
|
55
|
|
|
66,439
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Employee share-based compensation expense
|
—
|
|
|
—
|
|
|
83,019
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cumulative effect of accounting change (ASU 2016-16)
|
—
|
|
|
—
|
|
|
—
|
|
|
(22,439
|
)
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
36,783
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Treasury stock purchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(173,434
|
)
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
866,978
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at December 30, 2017
|
359,205
|
|
|
3,592
|
|
|
1,380,371
|
|
|
4,938,866
|
|
|
(1,464,099
|
)
|
|
(73,382
|
)
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Exercise of stock options (including net-settled option exercises)
|
3,008
|
|
|
30
|
|
|
83,768
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Employee share-based compensation expense
|
—
|
|
|
—
|
|
|
95,423
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cumulative effect of accounting change (ASU 2014-09)
|
—
|
|
|
—
|
|
|
—
|
|
|
7,600
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(30,170
|
)
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Treasury stock purchases
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(643,669
|
)
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
630,059
|
|
|
—
|
|
|
—
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at December 29, 2018
|
362,213
|
|
|
$
|
3,622
|
|
|
$
|
1,559,562
|
|
|
$
|
5,576,525
|
|
|
$
|
(2,107,768
|
)
|
|
$
|
(103,552
|
)
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
Cash paid during the year for:
|
|
|
|
|
|
||||||
Interest (including amounts capitalized of $12,710, $10,387, and $14,852, respectively)
|
$
|
15,707
|
|
|
$
|
17,914
|
|
|
$
|
18,484
|
|
Income taxes, net of refunds
|
(15,560
|
)
|
|
186,544
|
|
|
254,539
|
|
•
|
Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) are required to be measured at fair value with changes in fair value recognized in net earnings. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
|
•
|
The impairment assessment of equity investments without readily determinable fair values will require a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.
|
(In thousands)
|
|
|
Increase /
(Decrease)
|
||
|
|
|
|
||
Receivables, net
|
|
|
$
|
(79,492
|
)
|
Prepaid expenses and other
|
|
|
(2,253
|
)
|
|
Other assets
|
|
|
81,157
|
|
|
Accounts payable
|
|
|
(9,361
|
)
|
|
Deferred income taxes
|
|
|
1,173
|
|
|
Retained earnings
|
|
|
7,600
|
|
•
|
Perpetual software licenses - We recognize perpetual software license revenues when control of such licenses are transferred to the client ("point in time"). We determine the amount of consideration allocated to this performance obligation using the residual approach
.
|
•
|
Software as a service - We recognize software as a service ratably over the related hosting period ("over time")
.
|
•
|
Time-based software and content license fees - We recognize a license component of time-based software and content license fees upon delivery to the client ("point in time") and a non-license component (i.e. support) ratably over the respective contract term ("over time")
.
|
•
|
Hosting - Remote hosting recurring services are recognized ratably over the hosting service period ("over time"). Certain of our hosting arrangements contain fees deemed to be a "material right" under Topic 606. We recognize such fees over the term that will likely affect the client's decision about whether to renew the related hosting service ("over time")
.
|
•
|
Services - We recognize revenue for fixed fee services arrangements over time, utilizing a labor hours input method. For fee-for-service arrangements, we recognize revenue over time as hours are worked at the rates clients are
|
•
|
Support and maintenance - We recognize support and maintenance fees ratably over the related contract period ("over time")
.
|
•
|
Hardware - We recognize hardware revenues when control of such hardware/devices is transferred to the client ("point in time")
.
|
•
|
Transaction processing - We recognize transaction processing revenues ratably as we provide such services ("over time")
.
|
|
For the Years Ended
|
||||||||||||||||||||||||||||
|
2018
|
|
2017
(1)
|
|
2016
(1)
|
||||||||||||||||||||||||
(In thousands)
|
Domestic
Segment |
Global
Segment |
Total
|
|
Domestic
Segment |
Global
Segment |
Total
|
|
Domestic
Segment |
Global
Segment |
Total
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Licensed software
|
$
|
573,034
|
|
$
|
40,544
|
|
$
|
613,578
|
|
|
$
|
563,524
|
|
$
|
48,666
|
|
$
|
612,190
|
|
|
$
|
499,422
|
|
$
|
49,697
|
|
$
|
549,119
|
|
Technology resale
|
208,722
|
|
36,354
|
|
245,076
|
|
|
248,524
|
|
25,069
|
|
273,593
|
|
|
246,694
|
|
27,781
|
|
274,475
|
|
|||||||||
Subscriptions
|
300,555
|
|
25,154
|
|
325,709
|
|
|
446,426
|
|
22,963
|
|
469,389
|
|
|
416,311
|
|
26,057
|
|
442,368
|
|
|||||||||
Professional services
|
1,574,407
|
|
237,056
|
|
1,811,463
|
|
|
1,393,056
|
|
198,793
|
|
1,591,849
|
|
|
1,251,726
|
|
192,852
|
|
1,444,578
|
|
|||||||||
Managed services
|
1,060,081
|
|
94,860
|
|
1,154,941
|
|
|
970,609
|
|
76,523
|
|
1,047,132
|
|
|
909,584
|
|
71,993
|
|
981,577
|
|
|||||||||
Support and maintenance
|
921,336
|
|
196,780
|
|
1,118,116
|
|
|
856,304
|
|
190,352
|
|
1,046,656
|
|
|
838,745
|
|
177,066
|
|
1,015,811
|
|
|||||||||
Reimbursed travel
|
92,131
|
|
5,311
|
|
97,442
|
|
|
96,728
|
|
4,735
|
|
101,463
|
|
|
82,615
|
|
5,930
|
|
88,545
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Total revenues
|
$
|
4,730,266
|
|
$
|
636,059
|
|
$
|
5,366,325
|
|
|
$
|
4,575,171
|
|
$
|
567,101
|
|
$
|
5,142,272
|
|
|
$
|
4,245,097
|
|
$
|
551,376
|
|
$
|
4,796,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
(1)
As noted above, prior period amounts were not adjusted upon our adoption of Topic 606.
|
|
|
|
|
|
For the Year Ended
|
||||||||
|
2018
|
||||||||
(In thousands)
|
Domestic
Segment
|
Global
Segment
|
Total
|
||||||
|
|
|
|
||||||
Revenue recognized over time
|
$
|
4,271,934
|
|
$
|
569,780
|
|
$
|
4,841,714
|
|
Revenue recognized at a point in time
|
458,332
|
|
66,279
|
|
524,611
|
|
|||
|
|
|
|
||||||
Total revenues
|
$
|
4,730,266
|
|
$
|
636,059
|
|
$
|
5,366,325
|
|
•
|
Persuasive evidence of an arrangement existed;
|
•
|
Delivery had occurred or services had been rendered;
|
•
|
Our fee was fixed or determinable; and
|
•
|
Collection of the revenue was reasonably assured.
|
(In thousands)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Client receivables
|
$
|
1,237,127
|
|
|
$
|
1,082,886
|
|
Less: Allowance for doubtful accounts
|
64,561
|
|
|
52,786
|
|
||
|
|
|
|
||||
Client receivables, net of allowance
|
1,172,566
|
|
|
1,030,100
|
|
||
|
|
|
|
||||
Current portion of lease receivables
|
10,928
|
|
|
12,681
|
|
||
|
|
|
|
||||
Total receivables, net
|
$
|
1,183,494
|
|
|
$
|
1,042,781
|
|
(in thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Allowance for doubtful accounts - beginning balance
|
$
|
52,786
|
|
|
$
|
43,028
|
|
|
$
|
48,119
|
|
Additions charged to costs and expenses
|
25,529
|
|
|
29,248
|
|
|
5,060
|
|
|||
Deductions
(a)
|
(13,754
|
)
|
|
(19,490
|
)
|
|
(10,151
|
)
|
|||
|
|
|
|
|
|
||||||
Allowance for doubtful accounts - ending balance
|
$
|
64,561
|
|
|
$
|
52,786
|
|
|
$
|
43,028
|
|
|
|
|
|
|
|
||||||
(a)
Deductions in 2017 include a $13 million reclassification to other non-current assets.
|
|
|
|
|
|
(In thousands)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Minimum lease payments receivable
|
$
|
11,854
|
|
|
$
|
20,425
|
|
Less: Unearned income
|
926
|
|
|
1,447
|
|
||
|
|
|
|
||||
Total lease receivables
|
10,928
|
|
|
18,978
|
|
||
|
|
|
|
||||
Less: Long-term receivables included in other assets
|
—
|
|
|
6,297
|
|
||
|
|
|
|
||||
Current portion of lease receivables
|
$
|
10,928
|
|
|
$
|
12,681
|
|
(In thousands)
|
|
Adjusted Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
|
$
|
76,471
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
76,471
|
|
Time deposits
|
|
71,461
|
|
|
—
|
|
|
—
|
|
|
71,461
|
|
||||
Commercial paper
|
|
10,000
|
|
|
—
|
|
|
—
|
|
|
10,000
|
|
||||
Total cash equivalents
|
|
157,932
|
|
|
—
|
|
|
—
|
|
|
157,932
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
|
31,947
|
|
|
—
|
|
|
—
|
|
|
31,947
|
|
||||
Commercial paper
|
|
75,445
|
|
|
—
|
|
|
(91
|
)
|
|
75,354
|
|
||||
Government and corporate bonds
|
|
294,941
|
|
|
1
|
|
|
(958
|
)
|
|
293,984
|
|
||||
Total short-term investments
|
|
402,333
|
|
|
1
|
|
|
(1,049
|
)
|
|
401,285
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||
Government and corporate bonds
|
|
18,247
|
|
|
—
|
|
|
(55
|
)
|
|
18,192
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Total available-for-sale investments
|
|
$
|
578,512
|
|
|
$
|
1
|
|
|
$
|
(1,104
|
)
|
|
$
|
577,409
|
|
(In thousands)
|
|
Adjusted Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
|
$
|
99,472
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
99,472
|
|
Time deposits
|
|
60,226
|
|
|
—
|
|
|
—
|
|
|
60,226
|
|
||||
Government and corporate bonds
|
|
850
|
|
|
—
|
|
|
—
|
|
|
850
|
|
||||
Total cash equivalents
|
|
160,548
|
|
|
—
|
|
|
—
|
|
|
160,548
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
|
40,186
|
|
|
—
|
|
|
—
|
|
|
40,186
|
|
||||
Commercial paper
|
|
147,646
|
|
|
2
|
|
|
(139
|
)
|
|
147,509
|
|
||||
Government and corporate bonds
|
|
247,626
|
|
|
—
|
|
|
(477
|
)
|
|
247,149
|
|
||||
Total short-term investments
|
|
435,458
|
|
|
2
|
|
|
(616
|
)
|
|
434,844
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||
Government and corporate bonds
|
|
185,478
|
|
|
—
|
|
|
(1,026
|
)
|
|
184,452
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Total available-for-sale investments
|
|
$
|
781,484
|
|
|
$
|
2
|
|
|
$
|
(1,642
|
)
|
|
$
|
779,844
|
|
•
|
Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
|
•
|
Level 2 – Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
|
•
|
Level 3 – Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
(In thousands)
|
Depreciable Lives (Yrs)
|
|
2018
|
|
2017
|
||||||
|
|
|
|
|
|
|
|
||||
Computer and communications equipment
|
1
|
—
|
5
|
|
$
|
1,686,747
|
|
|
$
|
1,511,445
|
|
Land, buildings and improvements
|
12
|
—
|
50
|
|
1,239,122
|
|
|
1,051,658
|
|
||
Leasehold improvements
|
1
|
—
|
15
|
|
214,697
|
|
|
216,586
|
|
||
Furniture and fixtures
|
5
|
—
|
12
|
|
132,180
|
|
|
123,945
|
|
||
Capital lease equipment
|
3
|
—
|
5
|
|
—
|
|
|
3,197
|
|
||
Other equipment
|
3
|
—
|
20
|
|
1,255
|
|
|
1,161
|
|
||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
3,274,001
|
|
|
2,907,992
|
|
||
|
|
|
|
|
|
|
|
||||
Less accumulated depreciation and leasehold amortization
|
|
|
|
|
1,530,426
|
|
|
1,304,673
|
|
||
|
|
|
|
|
|
|
|
||||
Total property and equipment, net
|
|
|
|
|
$
|
1,743,575
|
|
|
$
|
1,603,319
|
|
(In thousands)
|
Domestic
|
|
Global
|
|
Total
|
||||||
|
|
|
|
|
|
||||||
Balance at the end of 2016
|
$
|
782,664
|
|
|
$
|
61,536
|
|
|
$
|
844,200
|
|
Foreign currency translation adjustment and other
|
—
|
|
|
8,805
|
|
|
8,805
|
|
|||
|
|
|
|
|
|
||||||
Balance at the end of 2017
|
782,664
|
|
|
70,341
|
|
|
853,005
|
|
|||
Foreign currency translation adjustment and other
|
—
|
|
|
(5,461
|
)
|
|
(5,461
|
)
|
|||
|
|
|
|
|
|
||||||
Balance at the end of 2018
|
$
|
782,664
|
|
|
$
|
64,880
|
|
|
$
|
847,544
|
|
|
2018
|
|
2017
|
||||||||||||
(In thousands)
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Customer lists
|
$
|
465,909
|
|
|
$
|
229,545
|
|
|
$
|
472,697
|
|
|
$
|
195,190
|
|
Purchased software
|
361,964
|
|
|
311,738
|
|
|
369,728
|
|
|
282,141
|
|
||||
Internal use software
|
143,520
|
|
|
78,633
|
|
|
114,574
|
|
|
60,924
|
|
||||
Trade names
|
40,025
|
|
|
21,275
|
|
|
41,224
|
|
|
16,961
|
|
||||
Other
|
47,905
|
|
|
12,827
|
|
|
46,581
|
|
|
9,835
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total
|
$
|
1,059,323
|
|
|
$
|
654,018
|
|
|
$
|
1,044,804
|
|
|
$
|
565,051
|
|
|
|
|
|
|
|
|
|
||||||||
Intangible assets, net
|
|
|
$
|
405,305
|
|
|
|
|
$
|
479,753
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Software development costs
|
$
|
747,128
|
|
|
$
|
705,944
|
|
|
$
|
704,882
|
|
Capitalized software development costs
|
(273,693
|
)
|
|
(274,148
|
)
|
|
(293,696
|
)
|
|||
Amortization of capitalized software development costs
|
210,228
|
|
|
173,250
|
|
|
140,232
|
|
|||
|
|
|
|
|
|
||||||
Total software development expense
|
$
|
683,663
|
|
|
$
|
605,046
|
|
|
$
|
551,418
|
|
(In thousands)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Senior Notes
|
$
|
425,000
|
|
|
$
|
500,000
|
|
Capital lease obligations
|
4,914
|
|
|
13,068
|
|
||
Other
|
14,162
|
|
|
14,162
|
|
||
|
|
|
|
||||
Debt and capital lease obligations
|
444,076
|
|
|
527,230
|
|
||
Less: debt issuance costs
|
(360
|
)
|
|
(515
|
)
|
||
|
|
|
|
||||
Debt and capital lease obligations, net
|
443,716
|
|
|
526,715
|
|
||
Less: current portion
|
(4,914
|
)
|
|
(11,585
|
)
|
||
|
|
|
|
||||
Long-term debt and capital lease obligations
|
$
|
438,802
|
|
|
$
|
515,130
|
|
|
Capital Lease Obligations
|
|
|
|
|
|
|
||||||||||||||||
(In thousands)
|
Minimum Lease Payments
|
|
Less: Interest
|
|
Principal
|
|
Senior Notes
|
|
Other
|
|
Total
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
2019
|
$
|
5,057
|
|
|
$
|
143
|
|
|
$
|
4,914
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,914
|
|
2020
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,500
|
|
|
2,500
|
|
||||||
2021
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
2022
|
—
|
|
|
—
|
|
|
—
|
|
|
225,000
|
|
|
1,100
|
|
|
226,100
|
|
||||||
2023
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,700
|
|
|
1,700
|
|
||||||
2024 and thereafter
|
—
|
|
|
—
|
|
|
—
|
|
|
200,000
|
|
|
8,862
|
|
|
208,862
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total
|
$
|
5,057
|
|
|
$
|
143
|
|
|
$
|
4,914
|
|
|
$
|
425,000
|
|
|
$
|
14,162
|
|
|
$
|
444,076
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Interest income
|
$
|
34,211
|
|
|
$
|
18,933
|
|
|
$
|
15,252
|
|
Interest expense
|
(7,987
|
)
|
|
(8,012
|
)
|
|
(4,479
|
)
|
|||
Other
|
(158
|
)
|
|
(4,263
|
)
|
|
(3,352
|
)
|
|||
|
|
|
|
|
|
||||||
Other income, net
|
$
|
26,066
|
|
|
$
|
6,658
|
|
|
$
|
7,421
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Current:
|
|
|
|
|
|
||||||
Federal
|
$
|
89,551
|
|
|
$
|
37,708
|
|
|
$
|
252,795
|
|
State
|
24,804
|
|
|
4,878
|
|
|
31,642
|
|
|||
Foreign
|
22,009
|
|
|
10,156
|
|
|
9,030
|
|
|||
Total current expense
|
136,364
|
|
|
52,742
|
|
|
293,467
|
|
|||
Deferred:
|
|
|
|
|
|
||||||
Federal
|
31,129
|
|
|
13,676
|
|
|
(18,014
|
)
|
|||
State
|
8,144
|
|
|
23,278
|
|
|
(2,103
|
)
|
|||
Foreign
|
(4,845
|
)
|
|
10,455
|
|
|
8,600
|
|
|||
Total deferred expense (benefit)
|
34,428
|
|
|
47,409
|
|
|
(11,517
|
)
|
|||
|
|
|
|
|
|
||||||
Total income tax expense
|
$
|
170,792
|
|
|
$
|
100,151
|
|
|
$
|
281,950
|
|
(In thousands)
|
2018
|
|
2017
|
||||
|
|
|
|
||||
Deferred tax assets:
|
|
|
|
||||
Accrued expenses
|
$
|
31,273
|
|
|
$
|
23,295
|
|
Tax credits and separate return net operating losses
|
22,826
|
|
|
26,304
|
|
||
Share-based compensation
|
60,901
|
|
|
56,263
|
|
||
Other
|
14,951
|
|
|
17,754
|
|
||
Gross deferred tax assets
|
129,951
|
|
|
123,616
|
|
||
Less: Valuation Allowance
|
(1,404
|
)
|
|
—
|
|
||
Total deferred tax assets
|
128,547
|
|
|
123,616
|
|
||
|
|
|
|
||||
Deferred tax liabilities:
|
|
|
|
||||
Software development costs
|
(229,624
|
)
|
|
(208,494
|
)
|
||
Depreciation and amortization
|
(131,516
|
)
|
|
(96,492
|
)
|
||
Prepaid expenses
|
(39,154
|
)
|
|
(21,214
|
)
|
||
Contract and service revenues and costs
|
(35,933
|
)
|
|
(65,043
|
)
|
||
Other
|
(6,199
|
)
|
|
(10,400
|
)
|
||
Total deferred tax liabilities
|
(442,426
|
)
|
|
(401,643
|
)
|
||
|
|
|
|
||||
Net deferred tax liability
|
$
|
(313,879
|
)
|
|
$
|
(278,027
|
)
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Tax expense at statutory rates
|
$
|
168,179
|
|
|
$
|
338,495
|
|
|
$
|
321,452
|
|
State income tax, net of federal benefit
|
25,321
|
|
|
22,214
|
|
|
22,644
|
|
|||
Tax credits
|
(19,737
|
)
|
|
(17,727
|
)
|
|
(23,881
|
)
|
|||
Foreign rate differential
|
(4,851
|
)
|
|
(26,379
|
)
|
|
(16,468
|
)
|
|||
Share-based compensation
|
(1,696
|
)
|
|
(62,501
|
)
|
|
—
|
|
|||
Change in U.S. tax rate
|
—
|
|
|
(170,999
|
)
|
|
—
|
|
|||
Deemed mandatory repatriation
|
—
|
|
|
25,114
|
|
|
—
|
|
|||
Permanent differences
|
6,224
|
|
|
(10,700
|
)
|
|
(20,330
|
)
|
|||
Other, net
|
(2,648
|
)
|
|
2,634
|
|
|
(1,467
|
)
|
|||
|
|
|
|
|
|
||||||
Total income tax expense
|
$
|
170,792
|
|
|
$
|
100,151
|
|
|
$
|
281,950
|
|
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Unrecognized tax benefit - beginning balance
|
$
|
15,287
|
|
|
$
|
9,769
|
|
|
$
|
4,878
|
|
Gross decreases - tax positions in prior periods
|
—
|
|
|
(1,734
|
)
|
|
—
|
|
|||
Gross increases - tax positions in prior periods
|
1,591
|
|
|
7,252
|
|
|
—
|
|
|||
Gross increases - tax positions in current year
|
2,370
|
|
|
—
|
|
|
6,945
|
|
|||
Settlements
|
(541
|
)
|
|
—
|
|
|
(1,859
|
)
|
|||
Currency translation
|
(19
|
)
|
|
—
|
|
|
(195
|
)
|
|||
|
|
|
|
|
|
||||||
Unrecognized tax benefit - ending balance
|
$
|
18,688
|
|
|
$
|
15,287
|
|
|
$
|
9,769
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||||||||||||||
|
Earnings
|
|
Shares
|
|
Per-Share
|
|
Earnings
|
|
Shares
|
|
Per-Share
|
|
Earnings
|
|
Shares
|
|
Per-Share
|
|||||||||||||||
(In thousands, except per share data)
|
(Numerator)
|
|
(Denominator)
|
|
Amount
|
|
(Numerator)
|
|
(Denominator)
|
|
Amount
|
|
(Numerator)
|
|
(Denominator)
|
|
Amount
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Basic earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income available to common shareholders
|
$
|
630,059
|
|
|
330,084
|
|
|
$
|
1.91
|
|
|
$
|
866,978
|
|
|
331,373
|
|
|
$
|
2.62
|
|
|
$
|
636,484
|
|
|
337,740
|
|
|
$
|
1.88
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Stock options and non-vested shares
|
—
|
|
|
3,488
|
|
|
|
|
—
|
|
|
6,626
|
|
|
|
|
—
|
|
|
5,913
|
|
|
|
|||||||||
Diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income available to common shareholders including assumed conversions
|
$
|
630,059
|
|
|
333,572
|
|
|
$
|
1.89
|
|
|
$
|
866,978
|
|
|
337,999
|
|
|
$
|
2.57
|
|
|
$
|
636,484
|
|
|
343,653
|
|
|
$
|
1.85
|
|
•
|
Expected volatilities under the BSM model are based on an equal weighting of implied volatilities from traded options on our common shares and historical volatility.
|
•
|
The expected term of stock options granted is the period of time for which an option is expected to be outstanding beginning on the grant date. Our calculation of expected term takes into account the contractual term of the option, as well as the effects of employees' historical exercise patterns; groups of associates (executives and non-executives) that have similar historical behavior are considered separately for valuation purposes.
|
•
|
The risk-free rate is based on the zero-coupon U.S. Treasury bond with a term consistent with the expected term of the awards.
|
|
|
For the Years Ended
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
|
|
|
|
|
|
|
|||
Expected volatility (%)
|
|
27.0
|
%
|
|
26.7
|
%
|
|
29.4
|
%
|
Expected term (yrs)
|
|
7
|
|
|
7
|
|
|
7
|
|
Risk-free rate (%)
|
|
2.8
|
%
|
|
2.1
|
%
|
|
1.5
|
%
|
(In thousands, except per share data)
|
Number of
Shares
|
|
Weighted-
Average
Exercise
Price
|
|
Aggregate
Intrinsic
Value
|
|
Weighted-Average
Remaining
Contractual
Term (Yrs)
|
|||||
Outstanding at beginning of year
|
21,332
|
|
|
$
|
49.40
|
|
|
|
|
|
||
Granted
|
3,598
|
|
|
58.35
|
|
|
|
|
|
|||
Exercised
|
(2,660
|
)
|
|
35.37
|
|
|
|
|
|
|||
Forfeited and expired
|
(478
|
)
|
|
62.46
|
|
|
|
|
|
|||
Outstanding at end of year
|
21,792
|
|
|
52.31
|
|
|
$
|
118,831
|
|
|
6.28
|
|
|
|
|
|
|
|
|
|
|||||
Exercisable at end of year
|
11,045
|
|
|
$
|
44.60
|
|
|
$
|
118,054
|
|
|
4.48
|
|
For the Years Ended
|
||||||||||
(In thousands, except for grant date fair values)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Weighted-average grant date fair values
|
$
|
20.13
|
|
|
$
|
20.50
|
|
|
$
|
18.31
|
|
|
|
|
|
|
|
||||||
Total intrinsic value of options exercised
|
$
|
74,530
|
|
|
$
|
252,277
|
|
|
$
|
177,375
|
|
|
|
|
|
|
|
||||||
Cash received from exercise of stock options
|
91,349
|
|
|
76,705
|
|
|
63,794
|
|
|||
|
|
|
|
|
|
||||||
Tax benefit realized upon exercise of stock options
|
17,233
|
|
|
85,657
|
|
|
64,347
|
|
(In thousands, except per share data)
|
Number of Shares
|
|
Weighted-Average
Grant Date Fair Value
|
|||
|
|
|
|
|||
Outstanding at beginning of year
|
799
|
|
|
$
|
66.76
|
|
Granted
|
537
|
|
|
59.34
|
|
|
Vested
|
(432
|
)
|
|
65.77
|
|
|
Forfeited
|
(22
|
)
|
|
62.94
|
|
|
|
|
|
|
|||
Outstanding at end of year
|
882
|
|
|
$
|
62.82
|
|
|
For the Years Ended
|
||||||||||
(In thousands, except for grant date fair values)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Weighted average grant date fair values for shares granted during the year
|
$
|
59.34
|
|
|
$
|
66.97
|
|
|
$
|
57.22
|
|
|
|
|
|
|
|
||||||
Total fair value of shares vested during the year
|
$
|
26,264
|
|
|
$
|
11,050
|
|
|
$
|
12,221
|
|
|
For the Years Ended
|
||||||||||
(In thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
|
|
|
|
|
||||||
Stock option and non-vested share and share unit compensation expense
|
$
|
95,423
|
|
|
$
|
83,019
|
|
|
$
|
74,536
|
|
Associate stock purchase plan expense
|
6,082
|
|
|
6,277
|
|
|
6,537
|
|
|||
Amounts capitalized in software development costs, net of amortization
|
914
|
|
|
(327
|
)
|
|
(482
|
)
|
|||
|
|
|
|
|
|
||||||
Amounts charged against earnings, before income tax benefit
|
$
|
102,419
|
|
|
$
|
88,969
|
|
|
$
|
80,591
|
|
|
|
|
|
|
|
||||||
Amount of related income tax benefit recognized in earnings
|
$
|
21,371
|
|
|
$
|
25,265
|
|
|
$
|
24,749
|
|
(In thousands)
|
Operating Lease Obligations
|
||
|
|
||
2019
|
$
|
29,739
|
|
2020
|
27,669
|
|
|
2021
|
22,904
|
|
|
2022
|
17,240
|
|
|
2023
|
10,166
|
|
|
2024 and thereafter
|
17,743
|
|
|
|
|
||
|
$
|
125,461
|
|
(In thousands)
|
Purchase Obligations
|
||
|
|
||
2019
|
$
|
138,851
|
|
2020
|
102,773
|
|
|
2021
|
24,746
|
|
|
2022
|
15,517
|
|
|
2023
|
15,486
|
|
|
2024 and thereafter
|
26,924
|
|
|
|
|
||
|
$
|
324,297
|
|
(In thousands)
|
Domestic
|
|
Global
|
|
Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
2018
|
|
|
|
|
|
|
|
||||||||
Revenues
|
$
|
4,730,266
|
|
|
$
|
636,059
|
|
|
$
|
—
|
|
|
$
|
5,366,325
|
|
|
|
|
|
|
|
|
|
||||||||
Costs of revenue
|
827,904
|
|
|
109,444
|
|
|
—
|
|
|
937,348
|
|
||||
Operating expenses
|
2,164,465
|
|
|
321,116
|
|
|
1,168,611
|
|
|
3,654,192
|
|
||||
Total costs and expenses
|
2,992,369
|
|
|
430,560
|
|
|
1,168,611
|
|
|
4,591,540
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Operating earnings (loss)
|
$
|
1,737,897
|
|
|
$
|
205,499
|
|
|
$
|
(1,168,611
|
)
|
|
$
|
774,785
|
|
(In thousands)
|
Domestic
|
|
Global
|
|
Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
2017
|
|
|
|
|
|
|
|
||||||||
Revenues
|
$
|
4,575,171
|
|
|
$
|
567,101
|
|
|
$
|
—
|
|
|
$
|
5,142,272
|
|
|
|
|
|
|
|
|
|
||||||||
Costs of revenue
|
755,729
|
|
|
98,362
|
|
|
—
|
|
|
854,091
|
|
||||
Operating expenses
|
1,998,544
|
|
|
264,196
|
|
|
1,064,970
|
|
|
3,327,710
|
|
||||
Total costs and expenses
|
2,754,273
|
|
|
362,558
|
|
|
1,064,970
|
|
|
4,181,801
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Operating earnings (loss)
|
$
|
1,820,898
|
|
|
$
|
204,543
|
|
|
$
|
(1,064,970
|
)
|
|
$
|
960,471
|
|
(In thousands)
|
Domestic
|
|
Global
|
|
Other
|
|
Total
|
||||||||
|
|
|
|
|
|
|
|
||||||||
2016
|
|
|
|
|
|
|
|
||||||||
Revenues
|
$
|
4,245,097
|
|
|
$
|
551,376
|
|
|
$
|
—
|
|
|
$
|
4,796,473
|
|
|
|
|
|
|
|
|
|
||||||||
Costs of revenue
|
676,437
|
|
|
102,679
|
|
|
—
|
|
|
779,116
|
|
||||
Operating expenses
|
1,774,146
|
|
|
246,243
|
|
|
1,085,955
|
|
|
3,106,344
|
|
||||
Total costs and expenses
|
2,450,583
|
|
|
348,922
|
|
|
1,085,955
|
|
|
3,885,460
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Operating earnings (loss)
|
$
|
1,794,514
|
|
|
$
|
202,454
|
|
|
$
|
(1,085,955
|
)
|
|
$
|
911,013
|
|
A.
|
You are the Executive Vice President, Worldwide Client Relationships of Cerner and have been employed by Cerner since July 14, 2003. You have been the Executive Vice President, Worldwide Client Relationships of Cerner since October 1, 2017.
|
B.
|
You entered into an employment agreement with Cerner dated July 14, 2003 (your “Employment Agreement”) and a mutual arbitration agreement with Cerner dated November 23, 2015.
|
C.
|
You and Cerner wish to amend your Employment Agreement by adding contractual severance terms as set forth in this Executive Severance Agreement.
|
D.
|
In consideration for your continuing employment with Cerner, the restricted stock granted to you on December 14, 2017, the potential severance payments and potential acceleration of the vesting of outstanding equity incentive awards described herein, the potential benefits to you in the event of a Change in Control, and other good and valuable consideration, the receipt and sufficiency of which you and Cerner hereby acknowledge, you and Cerner hereby agree to the following supplemental terms and conditions to your Employment Agreement.
|
E.
|
Definitions of capitalized terms used but not otherwise defined herein can be found in Appendix A.
|
1.
|
PARAGRAPH 2 MODIFICATION
. Paragraph 2 of your Employment Agreement is deleted in its entirety and replaced with the following:
|
A.
|
Type
. To the extent permitted by law, your employment relationship with Cerner is “at will,” which means that you may resign from Cerner at any time, for any reason or for no reason at all, and without advance notice (except as described below). It also means that Cerner may terminate your employment at any time - for any legally permitted reason or for no reason at all and without advance notice, subject to Cerner’s potential obligations to you under Paragraph 2.C below.
|
B.
|
Resignation and Termination
.
|
1.
|
Termination by Cerner
. Cerner may terminate your employment (i) at any time with or without Cause, or (ii) upon your Disability. Your employment with Cerner shall be deemed automatically terminated upon your death. Upon a termination of your employment by Cerner with Cause, due to your death or on account of Disability (each an “Ineligible Severance Event”), Cerner shall pay you within thirty (30) days following your last day of employment (x) any accrued but unpaid base salary, (y) any owed reimbursements for unreimbursed business expenses properly incurred by you prior to your termination date, which shall be subject to and paid in accordance with Cerner’s expense reimbursement policy; and (z) such employee benefits (including equity compensation or cash bonuses earned as of the termination date but not yet paid), if any, to which you may be entitled under Cerner's employee benefit plans as of
|
2.
|
Termination by You
. You may resign from your employment with Cerner at any time upon written notice to Cerner of your intention to resign from employment. Any resignation notice must be submitted to Cerner at least thirty (30) days prior to your intended last day of employment. Cerner, however, reserves the right either to accelerate your last day of employment or to allow your intended last day of employment to stand. If you resign with fewer than thirty (30) days’ notice, or if you actually leave Cerner’s employ prior to expiration of the notice period without the permission of Cerner, then you agree that (to the extent permitted by law) no Accrued Amounts from the date you submitted your resignation notice to your last day of employment will be owed or paid to you by Cerner. All other Accrued Amounts will be paid. You may also terminate your employment hereunder upon written notice to Cerner in the event of a Constructive Termination (before a Change in Control) or for Good Reason (after a Change in Control) and, subject to you satisfying your obligations under Paragraph 2.C.3 (Severance Agreement and Release), be entitled to certain severance and benefit compensation as provided in Paragraph 2.C.
|
C.
|
Severance and Benefits
.
|
1.
|
Non-Change in Control - Termination by Cerner for other than an Ineligible Severance Event or Resignation following Constructive Termination
. Subject to you satisfying your obligations under Paragraph 2.C.3. (Severance Agreement and Release), if, prior to a Change in Control or at any time after twelve (12) months following a Change in Control, (i) Cerner terminates your employment other than in connection with an Ineligible Severance Event or (ii) you resign from employment following a Constructive Termination, Cerner will within sixty (60) days (or later if required by Code Section 409A) of your termination of employment:
|
a.
|
Pay you your Accrued Amounts; and
|
b.
|
Commence severance payments to you equal to the sum of (i) two (2) year’s base salary (based on your annual base salary at the time of your termination), plus (ii) two (2) times the average annual cash bonus you received from Cerner during the three (3) years preceding the termination of your employment, less (iii) normal tax and payroll deductions. Such severance pay will be payable pro rata during the twenty-four (24) month severance term on Cerner’s regular paydays; and
|
c.
|
Commence payments to you having an aggregate value equal to twenty-four (24) times the difference between the monthly COBRA continuation premium cost to cover you and your dependents (to the extent covered under Cerner's health, vision and dental the plans on the date of your termination of employment) under Cerner's health, vision and dental plans in effect as of the date of your termination and the monthly amount you were paying for such coverage at the effective date of your termination. Such payments will be payable pro rata during the twenty-four (24) month severance term on Cerner’s regular paydays. Notwithstanding the foregoing, if Cerner making payments under this Paragraph 2.C.1.c would violate the nondiscrimination rules applicable to non-grandfathered plans under the Affordable Care Act or result in the imposition of penalties under the Affordable Care Act, the parties agree to reform this Paragraph 2.C.1.c in a manner as is necessary to comply with the Affordable Care Act; and
|
d.
|
With respect to outstanding equity awards, fully vest and, if applicable pay or deliver immediately, or a later date in conformity with Code Section 409A, any shares or other
|
2.
|
Change in Control - Termination by Cerner for other than an Ineligible Severance Event or Resignation for Good Reason.
Subject to you satisfying your obligations under Paragraph 2.C.3 (Severance Agreement and Release), if there is a Change in Control of Cerner and within twelve (12) months following the date such Change in Control becomes effective Cerner terminates your employment for any reason other than on account of an Ineligible Severance Event or you resign from employment with Good Reason, then Cerner will, within sixty (60) days (or later if required by Code Section 409A) of your termination of employment:
|
a.
|
Pay you your Accrued Amounts;
|
b.
|
Commence severance payments to you equal to the sum of (i) two (2) years’ base salary (based on your annual base salary at the time of your termination or resignation), plus (ii) two (2) times the average annual cash bonus you received from Cerner during the three (3) years preceding the termination or resignation of your employment, less (iii) normal tax and payroll deductions. Such severance pay will be payable in lump sum within sixty (60) days of the effective date of the termination of your employment;
|
c.
|
Commence payments to you having an aggregate value equal to twenty-four (24) times the difference between the monthly COBRA continuation premium cost to cover you and your dependents (to the extent covered under Cerner's health, vision and dental plans on the date of your termination of employment) under Cerner's health, vision and dental plans in effect as of the date of your termination and the monthly amount you were paying for such coverage at the effective date of your termination. Such payments will be payable pro rata during the twenty-four (24) month severance term on Cerner’s regular paydays. Notwithstanding the foregoing, if Cerner's making payments under this Paragraph 2.C.2.c would violate the nondiscrimination rules applicable to non-grandfathered plans under the Affordable Care Act or result in the imposition of penalties under the Affordable Care Act, the parties agree to reform this Paragraph 2.C.2.c in a manner as is necessary to comply with the Affordable Care Act; and
|
d.
|
Fully vest all outstanding unvested equity incentive awards granted to you under any Cerner equity incentive plans after June 1, 2005. For purposes of this Paragraph 2.C.2.d, any performance-based award shall become vested or settled assuming an "at-target" level of goal achievement had been attained.
|
3.
|
Severance Agreement and Release
. As a condition to your receiving severance in accordance with this Paragraph 2.C, upon your resignation or the termination of your employment, you agree to promptly execute and not revoke a written severance agreement, which release will be provided to you within ten (10) days of your termination date, containing normal and customary provisions, including but not limited to, a release releasing Cerner from any claims against Cerner related to your employment with Cerner that you might have at the time of or following the termination of your employment, and reasonable and customary representations and warranties.
|
4.
|
Forfeiture and Reimbursement
. Further, notwithstanding anything to the contrary in this Executive Severance Agreement, if you breach any confidentiality, non-competition or other material provision in your Employment Agreement following the termination of your employment with Cerner, Cerner’s obligation, if applicable, to deliver severance payments and benefits to you under this Paragraph 2.C, and the vesting of any equity incentive awards described in this Paragraph 2.C, will cease immediately, you will reimburse Cerner the amount of severance payments delivered to you by Cerner prior to such breach by you, and you will forfeit to Cerner all equity incentive awards (or the proceeds of exercised awards) that vested based on or after such termination of your employment and prior to your breach.
|
5.
|
ERISA Claims Review Procedures
. To the extent any severance payments described in this Paragraph 2.C are covered by the Employee Retirement Income Security Act of 1974, as amended, Claims Review Procedures are available from Cerner.
|
6.
|
Compliance with Section 409A
.
|
a.
|
General Compliance
. This Executive Severance Agreement and any severance payments contemplated to be made hereunder is intended to comply with Section 409A or an exemption thereunder and shall be construed and administered in accordance with Section 409A. Notwithstanding any other provision of this Executive Severance Agreement, payments provided under this Executive Severance Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any payments under this Executive Severance Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this Executive Severance Agreement shall be treated as a separate payment. Any payments to be made under this Executive Severance Agreement upon a termination of employment shall only be made upon a "separation from service" under Section 409A. Notwithstanding the foregoing, Cerner makes no representations that the payments and benefits provided under this Executive Severance Agreement comply with Section 409A, and in no event shall Cerner be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by you on account of non-compliance with Section 409A.
|
b.
|
Specified Employees
. Notwithstanding any other provision of this Executive Severance Agreement, if any payment or benefit provided to you in connection with your termination of employment is determined to constitute "nonqualified deferred compensation" within the meaning of Section 409A and you are determined to be a "specified employee" as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of the your termination date or, if earlier, on your death (the "Specified Employee Payment Date"). The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date shall be paid to you in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule.
|
c.
|
Reimbursements
. To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Executive Severance Agreement shall be provided in accordance with the following:
|
i.
|
the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year;
|
ii.
|
any reimbursement of an eligible expense shall be paid to you on or before the last day of the calendar year following the calendar year in which the expense was incurred; and
|
iii.
|
any right to reimbursements or in-kind benefits under this Executive Severance Agreement shall not be subject to liquidation or exchange for another benefit.
|
D.
|
Partial Accelerated Vesting upon a Change in Control
. In connection with a Change in Control, 50% of each outstanding and unvested equity incentive award granted to you under any Cerner equity incentive plan after June 1, 2005 and prior to the date of the Change in Control becomes effective will become vested on the date the Change in Control becomes effective. The remaining 50% of each such outstanding equity incentive award that has not yet vested will continue to vest according to its
|
E.
|
Modified 280G Carve-Back
. Notwithstanding anything contained in this Executive Severance Agreement to the contrary, if on an after-tax basis the aggregate payments and benefits paid pursuant to Paragraph 2.C.2 or Paragraph 2.D would be larger if the portion of such payments and benefits constituting "parachute payments" under Code Section 280G were reduced by the minimum amount necessary to avoid the imposition of the excise tax under Code Section 4999, then such payments and benefits shall be reduced by the minimum amount necessary to avoid such excise tax. Any such reduction shall occur in a manner that maximizes your economic position. In applying this principle, the reduction shall be made in a manner consistent with the requirements of Section 409A, and where two economically equivalent amounts are subject to reduction but payable at different times, such amounts shall be reduced on a pro rata basis but not below zero. Any determination required under this Paragraph 2.E shall be made in writing in good faith by an accounting firm selected by Cerner, which is reasonably acceptable to you (the “Accountants”). Cerner and you shall provide the Accountants with such information and documents as the Accountants may reasonably request in order to make a determination under this Paragraph 2.E. Cerner shall be responsible for all fees and expenses of the Accountants.
|
F.
|
409(a) Modifications
. Notwithstanding anything to the contrary herein, Cerner may modify your Employment Agreement and this Executive Severance Agreement from time to time without your consent if Cerner’s legal counsel deems doing so to be advisable to comply with Section 409A of the Code and you agree that any such modifications shall be binding upon you.
|
G.
|
Relocation
. Cerner may pay or reimburse you for certain reasonable costs associated with any relocation required by Cerner in conjunction with a position with Cerner pursuant to the terms of Cerner’s published relocation policy, as may be amended from time to time. In the event that Cerner pays or reimburses you for any relocation costs, you agree to repay such sums to Cerner in accordance with the terms of the relocation policy in effect at the time of your move if (i) you voluntarily resign from employment with Cerner for any reason within two (2) years of the date your relocation is complete or (ii) Cerner terminates your employment due to your dishonesty, illegal conduct or breach of Cerner’s policies or this Agreement within two (2) years of the date your relocation is complete. You further agree that Cerner may, at its discretion, deduct from your paycheck(s), including your final paycheck, any such sums required to be repaid under this provision and that you will repay Cerner any outstanding balance owed within 30 days of your employment termination. Regardless of the duration stated herein, nothing contained in this provision shall create employment for a definite term or otherwise modify the parties “at will” relationship set forth in Paragraph 2.A of this Agreement. This allowance applies to full-time associates on a discretionary basis and only applies to part-time associates as specifically made eligible.
|
H.
|
Other Assistance
. Cerner may pay or reimburse you for certain reasonable costs associated with Other Assistance Programs in which Cerner provides assistance, pursuant to the terms of such Other Assistance Programs' policies, as may be amended from time to time. In the event that Cerner pays or reimburses you for any costs associated with such Other Assistance Programs, you agree to repay such sums to Cerner in accordance with the terms of the applicable Other Assistance Programs policy in effect at the time of you participation in such Other Assistance Program if (i) you voluntarily resign from employment with Cerner for any reason within two (2) years of the date of your participation in the application Program is complete, or (ii) Cerner terminates your employment due to your dishonesty, illegal conduct, or breach of Cerner's policies or this Agreement within two (2) years of the date you participation in the applicable program is complete. You further agree that Cerner may, at its discretion, deduct from your paycheck(s), including your final paycheck, any such sums required to be repaid under this provision and that you will repay Cerner any outstanding balance owed within 30 days of
|
I.
|
Sales Associate/Cerner Consulting Provisions
. If you are employed by Cerner in a sales capacity or in certain Cerner Consulting roles, additional provisions incorporated as Attachment IV to this Agreement are applicable to your employment relationship.
|
2.
|
PARAGRAPH 3 MODIFICATION
. The following is added to Paragraph 3 of your Employment Agreement:
|
3.
|
ENTIRE AGREEMENT AND PRIOR AGREEMENTS
.
|
1.
|
CERNER'S LETTER OFFERING EMPLOYMENT TO YOU.
|
2.
|
EMPLOYMENT RELATIONSHIP.
|
A.
|
Formation.
By signing this Agreement, you represent that every material fact contained in your resume and application for employment with Cerner is true and accurate to the best of your knowledge and belief. You also agree that falsification of your resume or application is grounds for immediate discharge.
|
B.
|
Type.
To the extent permitted by law, your employment relationship with Cerner is "at will", which means that you may resign from Cerner at any time, for any reason, or for no reason at all, and without advance notice (except as described below). It also means that Cerner may terminate your employment at any time, for any legally permitted reason, or for no reason at all, and without advance notice.
|
C.
|
Resignation and Termination.
You agree to cooperate with Cerner by participating fully in an exit interview in the event you leave the employ of Cerner. You agree to give Cerner written notice of your intention to resign from employment at least ten (10) business days prior to the last day you intend to work at Cerner. To facilitate the provisions of paragraphs 7 and 8 of this agreement, you also agree to report to Cerner, in conjunction with your written notice of intent, the identity of your new employer (if any) and the nature of your proposed duties for that employer. Cerner, however, reserves the right either to accelerate your intended effective termination date to an earlier actual date or to allow your intended effective termination date to stand.
|
D.
|
SALES ASSOCIATE/CERNER CONSULTING PROVISIONS.
If you are employed by Cerner in a sales capacity or in certain Cerner Consulting roles, additional provisions incorporated as Attachment IV to this Agreement are applicable to your employment relationship.
|
3.
|
AGREEMENT NOT TO DISCLOSE OR TO USE CONFIDENTIAL INFORMATION.
|
4.
|
NON-CERNER EMPLOYMENT.
|
5.
|
NEW PRODUCTS AND IDEAS.
|
6.
|
PRIOR INVENTIONS.
|
7.
|
NON-COMPETITION AND NON-SOLICITATION.
|
A.
|
You will
tell any prospective new employer, prior to accepting employment that this Employment Agreement exists.
|
B.
|
If you have worked for Cerner in a sales capacity, you will not provide services to any Conflicting Organization in connection with the marketing, sale or promotion of any Conflicting Product to any person or organization upon whom you called or whose account you supervised on behalf of Cerner any time during the last three (3) years of your employment by Cerner.
|
C.
|
If you have worked for Cerner in a non-sales capacity during the last three years of your employment by Cerner, you will not provide services directly or indirectly related to your employment at Cerner to any Conflicting Organization in the United States or in any country in which Cerner has a business interest. However, you may accept employment with a large Conflicting Organization whose business is diversified, and with a portion of its business that is not a Conflicting Organization, provided that Cerner, prior to your acceptance of such employment, shall receive separate written assurances satisfactory to Cerner from such Conflicting Organization and from you that you will not render services directly or indirectly in connection with any Conflicting Product.
|
D.
|
Notwithstanding the foregoing, nothing contained in this Paragraph 7 shall prohibit you (after your termination of employment with Cerner) from taking a position with a general consulting organization whose only Conflicting Product is the provision of consulting services to the healthcare industry, so long as you personally do not thereby provide or assist in providing consulting services to a Client with respect to any Cerner product, process or service or any Conflicting Product.
|
E.
|
You agree not, on behalf of yourself or on behalf of any other person, entity, or organization, to employ, solicit for employment, or otherwise seek to employ or retain any Cerner associate or employee, or any employee of a Cerner client company, or in any way assist or facilitate any such employment, solicitation, or retention effort.
|
8.
|
POST-TERMINATION PAYMENTS BY CERNER.
|
A.
|
Written permission to accept available employment, or
|
B.
|
A written release from the non-competition obligations set forth in Paragraph 7 of this Agreement.
|
9.
|
PUBLICITY RELEASE.
|
10.
|
CERNER PROPERTY.
|
11.
|
SYSTEMS AND PHYSICAL SECURITY.
|
12.
|
PRIOR EMPLOYMENT RELATIONSHIPS AND OBLIGATIONS.
|
13.
|
REMEDIES.
|
14.
|
INDEMNIFICATION.
|
15.
|
MODIFICATION.
|
16.
|
NOTICES.
|
17.
|
TERM OF THIS AGREEMENT.
|
18.
|
GOVERNING LAW; JURISDICTION.
|
19.
|
SEVERABILITY.
|
20.
|
ENTIRE AGREEMENT AND PRIOR AGREEMENTS.
|
21.
|
SUCCESSORS.
|
/s/ John T. Peterzalek
|
Associate
|
|
|
Cerner Corporation
|
|
/s/ Cerner Representative
|
Cerner Human Resources
|
Included
|
|
Not
Included
|
|
Attachment
|
Description
|
|
|
|
|
|
|
X
|
|
|
|
I
|
Original Offer Letter
|
|
|
|
|
II
|
Offer Letter Amendments
|
X
|
|
|
|
III
|
Termination Statement
|
X
|
|
|
|
IV
|
Sales Associate Provisions
|
|
|
|
|
V
|
Inventory of Prior Inventions
|
1.
|
I have not improperly disclosed or otherwise misused any of the Confidential Information covered by such Agreement. I shall continue to comply with all the continuing terms of the Agreement, including but not limited to the non-disclosure and (for the required term) non-compete provisions, and also including but not limited to the reporting of any New Products and Ideas conceived or made by me as covered by the Agreement.
|
2.
|
I do not have in my possession, nor have I taken with me or failed to return, any records, plans, information, drawings, designs, documents, manuals, formulae, statistics, correspondence, client and vendor lists, specifications, blueprints, reproductions, sketches, notes, reports, proposals, or other documents or materials, or copies of them, or any equipment (including any laptops, computer equipment, office equipment, wireless telephone, pagers and/or other computer or communication devices provided to you by Cerner), credit cards or other property belonging to Cerner or its Clients or Vendors. I have returned to Cerner (or will return within 10 calendar days or earlier if requested by Cerner) all material and information compiled or received by me during the term of such employment. I have returned (or will return within 10 calendar days or earlier if requested by Cerner) all Confidential Information, as specified by such Agreement, and all correspondence and other writings. I have returned (or will return within 10 calendar days or earlier if requested by Cerner) all keys and other means of access to Cerner's premises. Failure to return such Cerner Property as defined in Section 10 of my Employment Agreement will result in any vacation pay that is due to me under the terms of Cerner's vacation policy to be withheld until the return to Cerner of all such Cerner Property.
|
3.
|
I understand and agree that, with regard to all provisions of this Agreement relating to non-disclosure, non-solicitation, and confidentiality of information, such provisions shall not cease as of this termination but shall continue in full force and effect in perpetuity or as otherwise indicated within this Agreement. In compliance with the Agreement, I shall continue to preserve as confidential all Confidential Information as defined in the Agreement.
|
|
Associate Signature Printed Name & Associate #
|
|
Date
|
|
Termination Date
|
|
Cerner Corporation
|
|
By
|
|
Title
|
|
1.
|
Cerner reserves the right to offset any advances made to me against commissions or other amounts which I owe to Cerner, against available but unpaid salary, commissions payable, accrued vacation, expense reimbursement, or any other forms of compensation or reimbursement which may be owed to me. Any such offsets will be clearly documented by Cerner before they are processed. In addition, I agree that I will pay to Cerner the amount of any remaining balance owed to Cerner Corporation after the foregoing deductions, within 30 days of the end of my employment.
|
2.
|
Any commissions to which I might otherwise be entitled will be payable to me only if the associated contract for products or services has been completed and fully executed by both parties, and if all deposit monies related to such contract have been paid in full by the client and received by Cerner prior to my last date of employment, in accordance with the terms of my Cerner Performance Plan. Cerner will not unreasonably delay or withhold execution of such contracts for the purpose of avoiding a commission payment to me, if it would otherwise be due.
|
3.
|
Commissions, bonuses or other incentive-based compensation which may have accrued but are not payable as of my termination date because of the payment schedule defined for such compensation in the related Cerner Performance Plan will be paid to me according to the provisions of such Plan. Such payment will be subject to the offsets described in item 1 above and will apply only to items otherwise payable within one year following my termination date.
|
|
Associate
|
|
Date
|
|
Termination Date
|
|
Cerner Corporation
|
|
By
|
|
Title
|
|
(i)
|
grant options and authorize the issuance of shares;
|
(ii)
|
make and amend all rules, regulations, guidelines, procedures and policies for administering the Plan;
|
(iii)
|
decide all questions and settle all disputes that may arise in connection with the Plan;
|
(iv)
|
appoint persons and entities to act as designated representatives on the Administrator’s behalf in administering the Plan pursuant to its provisions (in which case the term “Administrator” as used herein shall include such persons or entities to the extent of such appointment);
|
(v)
|
establish accounts with a person or entity appointed pursuant to (iv) above (“Custodian”) to hold Common Stock purchased under the Plan (“Stock Account”);
|
(vi)
|
cause Cerner to enter into a written agreement with the Custodian setting forth the terms and conditions upon which Stock Accounts shall be governed (“Custodial Agreement”); and
|
(vii)
|
require Participants to hold shares of Common Stock under the Plan in Stock Accounts (in which case each Participant’s decision to participate in the Plan shall constitute the appointment of such Custodian as custodial agent for the purpose of holding such shares) until such time as shall be specified in the Custodial Agreement.
|
(i)
|
The number of shares which may be purchasable by a Participant during his or her first Option Period during a calendar year may not exceed a number of shares determined by dividing $25,000 by the Fair Market Value of a Share on the Grant Date for that Option Period.
|
(ii)
|
The number of shares which may be purchasable by a Participant during any subsequent Option Period during the same calendar year (if any) shall not exceed the number of Shares determined by performing the calculation below:
|
(B)
|
Second, the sum of all amounts calculated under (A) above (for all Option Periods) shall be calculated.
|
(C)
|
Third, the amount determined under (B) above shall be subtracted from $25,000.
|
(D)
|
Fourth, the amount determined under (C) above shall be divided by the Fair Market Value of a Share on the Grant Date for such subsequent Option Period (for which the maximum number of Shares purchasable is being determined by this calculation) occurs. The quotient thus obtained shall be the maximum number of Shares which may be purchased by any Participant for such subsequent Option Period.
|
(i)
|
increase the number of shares reserved for purchase under the Plan, unless such increase is by reason of any change in the capital structure of Cerner referred to in Section 3 hereof;
|
(ii)
|
change the designation of corporations or other entities whose employees may be offered Options under the Plan, except as permitted under Treasury Regulations §1.423-2(c)(4);
|
(iii)
|
materially modify the requirements as to eligibility for participation in the Plan; or
|
(iv)
|
materially increase the benefits accruing to Participants under the Plan.
|
SUBSIDIARIES OF REGISTRANT
|
|
Name
|
State/Country of Incorporation
|
|
|
1. Cerner Belgium SPRL
|
Belgium
|
2. Cerner Campus Redevelopment Corporation
|
Missouri
|
3. Cerner Canada Limited LLC
|
Delaware
|
4. Cerner Canada ULC
|
Canada
|
5. Cerner Capital, Inc.
|
Delaware
|
6. Cerner Chile Limitada
|
Chile
|
7. Cerner Chouteau Data Center, Inc.
|
Delaware
|
8. Cerner Corporation PTY Limited
|
New South Wales (Australia)
|
9. Cerner Deutschland GmbH
|
Germany
|
10. Cerner Egypt L.L.C
|
Egypt
|
11. Cerner Finland Oy
|
Finland
|
12. Cerner France SAS
|
France
|
13. Cerner Galt, Inc.
|
Delaware
|
14. Cerner Global Holdings B.V.
|
Netherlands
|
15. Cerner Government Services, Inc.
|
Delaware
|
16. Cerner Healthcare Sales India Private Limited
|
India
|
17. Cerner Healthcare Solutions, Inc.
|
Delaware
|
18. Cerner Healthcare Solutions India Private Limited
|
India
|
19. Cerner Health Connections, Inc.
|
Delaware
|
20. Cerner Health Services, Inc.
|
Delaware
|
21. Cerner Health Services Deutschland GmbH
|
Germany
|
22. Cerner Iberia, S.L.U.
|
Spain
|
23. Cerner Innovation, Inc.
|
Delaware
|
24. Cerner International, Inc.
|
Delaware
|
25. Cerner Ireland Limited
|
Ireland
|
26. Cerner Legal, Quality & Strategy, Inc.
|
Delaware
|
27. Cerner Limited
|
United Kingdom
|
28. Cerner Lingologix, Inc.
|
Delaware
|
29. Cerner (Malaysia) SDN BHD
|
Malaysia
|
30. Cerner Math, Inc.
|
Delaware
|
31. Cerner México, S. de R. L. de C.V.
|
Mexico
|
32. Cerner Middle East FZ-LLC
|
Emirate of Dubai, UAE
|
33. Cerner Middle East, Ltd.
|
Cayman Islands
|
34. Cerner Multum, Inc.
|
Delaware
|
35. Cerner Nederland B.V.
|
Netherlands
|
36. Cerner Norge AS
|
Norway
|
37. Cerner Österreich GmbH
|
Austria
|
38. Cerner Portugal Unipessoal, Lda.
|
Portugal
|
39. Cerner Properties, Inc.
|
Delaware
|
40. Cerner Property Development, Inc.
|
Delaware
|
41. Cerner RevWorks, LLC
|
Delaware
|
42. Cerner România S.R.L.
|
Romania
|
43. Cerner Singapore Limited LLC
|
Delaware
|
44. Cerner Soluções para a Saúde Ltda.
|
Brazil
|
45. Cerner State & Local Government Services, Inc.
|
Delaware
|
46. Cerner Sverige AB
|
Sweden
|
47. Cerner Universal Revenue Cycle Management, LLC
|
Delaware
|
48. Rockcreek Aviation, Inc.
|
Delaware
|
49. The Health Exchange, Inc.
|
Missouri
|
|
|
|
|
|
|
|
|
|
Date: February 8, 2019
|
|
|
|
|
|
/s/ Brent Shafer
|
|
|
|
|
|
|
|
|
Brent Shafer
|
|
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
|
|
Date: February 8, 2019
|
|
|
|
|
|
/s/ Marc G. Naughton
|
|
|
|
|
|
|
|
|
Marc G. Naughton
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
(Principal Financial Officer)
|
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Brent Shafer
|
Brent Shafer, Chief Executive Officer
|
(Principal Executive Officer)
|
Date: February 8, 2019
|
1.
|
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Marc G. Naughton
|
Marc G. Naughton, Executive Vice President
|
and Chief Financial Officer
|
(Principal Financial Officer)
|
Date: February 8, 2019
|